Curriculum VitaeLast Updated: 08/09/2018

PERSONAL DATAName: Matthew T. RondinaCitizenship: United States

EDUCATIONYears Degree Institution (Area of Study)1996 - 1998 B.S. University of Utah (Psychology)

Salt Lake City, UT1999 - 2003 M.D. University of Utah Medical School (Medicine)

Salt Lake City, UT2003 - 2004 Intern University of Utah Health Sciences Center (Internal Medicine)

Salt Lake City, UT2004 - 2006 Resident University of Utah Health Sciences Center (Internal Medicine)

Salt Lake City, UT2006 - 2007 Intern University of Utah (Internal Medicine)

Salt Lake City, UT2009 - 2012 M.S. University of Utah (Clinical Investigation)

Salt Lake City, UT

BOARD CERTIFICATIONS07/30/2007 - Present American Board of Internal Medicine (Internal Medicine), Certified

ACADEMIC HISTORYInternal Medicine (General Internal Medicine), 07/01/2007 - Present07/01/2007 Hire, Clinical/(Clinical) Track, Assistant Professor (Clinical)01/01/2010 Track Switch, Tenure Track - Clinician Scholar, Assistant Professor07/01/2014 Promotion, Associate Professor07/01/2014 Tenure, Associate Professor

Pathology (Microbiology and Immunology), 09/01/2017 - Present09/01/2017 Hire, Adjunct Track, Adjunct Associate Professor

PROFESSIONAL EXPERIENCE

Full-Time Positions2006 - 2007 Chief Medical Resident, University of Utah Hospital, Salt Lake City, UT2007 - 2014 Assistant Professor, University of Utah, Salt Lake City, UT2007 - 2015 Co-Director, University Health Care Thrombosis Service, Salt Lake City, UT2011 - Present Investigator, Molecular Medicine (U2M2) Program, University of Utah, Salt Lake

City, UT2014 - Present Associate Professor, George E. Whalen Veterans Affairs Medical Center, Salt

Lake City, UT2014 - Present Associate Professor, University of Utah, Salt Lake City, UT

Rondina, Page 1

2015 - Present Associate Director, CCTS Clinical Services Foundation, University of Utah, SaltLake City, UT

2015 - Present Director, Precision Medicine Foundation, Center for Clinical and TranslationalScience (CCTS), University of Utah, Salt Lake City, UT

2016 - Present Investigator, Geriartric Research Education and Clinical Center (GRECC), GeorgeE. Whalen Veterans Affairs Medical Center, Salt Lake City, UT

2017 - Present Associate Professor (Adjunct), Department of Pathology, University of Utah, SaltLake City, UT

2017 - 2018 Interim Associate Director, Molecular Medicine (U2M2) Program, University ofUtah, Salt Lake City, UT

2018 - Present Medical Director, Anticoagulation Service, George E. Whalen Veterans AffairsMedical Center, Salt Lake City, UT

2018 - Present Director, Molecular Medicine (U2M2) Program, University of Utah, Salt LakeCity, UT

Editorial Experience2014 - Present Review Editor for Frontiers in Hematology2016 - Present Editorial Board Member, Blood Advances2017 - Present Section Editor, Journal of Thrombosis and Thrombolysis

Reviewer ExperienceReferee, American Journal of PhysiologyReferee, American Journal of Respiratory and Critical Care MedicineReferee, Annals of HematologyReferee, Arteriosclerosis, Thrombosis, and Vascular BiologyReferee, BloodReferee, Blood AdvancesReferee, BMC ImmunologyReferee, CirculationReferee, Circulation ResearchReferee, Clinical Applied Thrombosis and HaemostasisReferee, Critical Care MedicineReferee, DiabetesReferee, HaematologicaReferee, Infection and ImmunityReferee, JAMAReferee, Journal of Infectious DiseaseReferee, Journal of the American College of CardiologyReferee, Journal of the American Society of NephrologyReferee, Journal of Thrombosis and HaemostasisReferee, PLOS OneReferee, ScienceReferee, Scientific ReportsReferee, Thrombosis HaemostasisReferee, Trends in Pharmacological Sciences

SCHOLASTIC HONORS

Rondina, Page 2

1996 Alpha Omega Delta1997 Phi Kappa Phi2000 Student Scholar in Cardiovascular Disease and Stroke, American Heart

Association2002 Outstanding Medical Student, University of Utah Health Science Center2003 National Poster Award, American College of Physicians2005 National Research Competition Winner, American College of Physicians2006 Resident of the Year, University of Utah Department of Internal Medicine2008 K-12 Scholar's Award, University of Utah Health Sciences Center2009 Outstanding Paper of the Year Award, ACCP Cardiology2010 Leonard W. Jarcho, M.D. Distinguished Teaching Award Nominee, University of

Utah Health Sciences Center2011 Travelling Fellowship Award, North American Thrombosis Forum2011 Highlighted Poster, International Society of Thrombosis and Haemostasis Meeting2011 Presidential Poster Award, National American Geriatric Society Meeting2011 GEMSSTAR (Grants for Early Medical and Surgical Subspecialists Transition to

Aging Research) Scholar2011 - 2014 Awardee, NIH Loan Repayment Program2011 Young Investigator Award, American College of Chest Physicians2012 New Investigator Award, American Geriatric Society2012 William D. Odell Young Investigator Award, University of Utah, Department of

Internal Medicine2013 ASCI Council's Young Physician-Scientist Award2013 Golden Anniversary Prize for Distinguished Clinical Investigation, University of

Utah School of Medicine Alumni Association2014 Member, Early Career Reviewer (ECR) Program at the Center for Scientific

Review (CSR), National Institutes of Health2015 Fellow, American Heart Association2015 Fellow, American College of Physicians2015 - 2017 Visiting Honorary Professorship, Chinese Foreign Ministry2017 Best Scientific Abstract, SGIM Mountain West Regional Meeting2017 University of Utah Vitae2018 University of Utah Research Instrumentation Grant

ADMINISTRATIVE EXPERIENCE

Professional Organization & Scientific Activities2005 Resident Representative, American College of Physicians, "Research for the

Young Hospitalist", National Society of Hospital Medicine Meeting in Chicago2005 - 2007 Chair, American College of Physicians, Associate Member2005 - 2008 Committee Member, Society of Hospital Medicine Young Physicians2005 - 2008 Council Member, American College of Physicians2008 Reviewer, American College of Physicians, Student Leadership Day2014 - Present Invited Member, American Society of Hematology, Scientific Committee on

Platelets2015 Chair, International Society on Thrombosis and Haemostasis, Genetic Basis of

Platelet Disorders2016 Chair, Anticoagulation Forum, VTE Educational Experience

Rondina, Page 3

2017 Committee Member, American Society of Hematology, 2017 ASH Workshop onHematology and Aging

2018 - Present Co-Chair, International Society on Thrombosis and Haemostasis, ISTH Scientificand Standarization Committee (SSC) on Platelet Physiology

2018 - Present Senior Advisor, ClinGen Clinical Genome Resource, American Society ofHematology, Platelet Disorder Working Group

Grant Review Committee/Study Section2005 - 2006 Canadian Institutes of Health Research2012 R21 Special Emphasis Panel, National Institutes of Health2013 U24/U34 Special Emphasis Panel, National Institutes of Health2013 - 2014 Vascular Wall Biology, American Heart Association2013 - 2016 K99/R00 Mentored Transition to Independence, National Institutes of Health2014 University of Utah CCTS K12 Career Development Award2015 University of Utah Program in Personalized Health2015 AHA Innovative Research Grant Study Section2017 Canadian Institutes of Health Research

Haematology, Digestive Disease, and Kidney Study Section (CIHR-HDK)2017 - Present University of Utah KL2 Program2018 Deutsche Forschungsgemeinschaft (DFG)

Transregional Collaborative Research Centre, Germany2018 CCTS Pilot Grant Reviewer, University of Utah, Salt Lake City, UT2018 Canadian Institutes of Health Research

Haematology, Digestive Disease, and Kidney Study Section (CIHR-HDK)2018 NHLBI, ZHL1 CSR-C UO1 Consortium Linking Oncology with Thrombosis

(CLOT)

PROFESSIONAL COMMUNITY ACTIVITIES1996 - 1998 Volunteer, Homeless Shelter, Preventive Medicine Instructor, Salt Lake City,Utah1997 - 1999 Volunteer Instructor, American Red Cross, BCLS1999 - 2002 Volunteer, Fourth Street Homeless Clinic1999 - 2002 Volunteer, Summer Program for Future Doctors2003 Medical Volunteer, Salt Lake City Marathon2008 - 2009 Member, Utah Medicaid, Pharmacy and Therapeutics Committee2008 Invited Guest, ABC 4 - Good Things Utah, Venous Thromboembolism Awareness2009 - 2016 Member, Public Employees Health Program, Pharmacy and Therapeutics

Committee

UNIVERSITY COMMUNITY ACTIVITIES

Health Sciences Level2004 Housestaff Representative, Health Sciences Center, Special Committee on Alcohol

Withdrawal Protocols2004 - 2006 Housestaff Representative, Health Sciences Center, Pharmacy and Therapeutics

Committee2008 - 2009 Project Leader, Health Sciences Center, National Patient Safety Goals:

Anticoagulation Protocol and Policy Development.

Rondina, Page 4

2012 - Present Member, Center for Clinical and Translational Science, Internal AdvisoryCommittee

2015 - Present Chair, Center for Clinical and Translational Science, CTRC BiorepositoryExecutive Committee

University Hospitals & Clinics1997 - 1998 Volunteer, University Hospital, Emergency Department2009 - 2010 Chair, University of Utah Hospitals and Clinics, Thrombosis Inpatient Management

Working Group2009 - Present Faculty Instructor, University of Utah Hospitals and Clinics, Heparin-Induced

Thrombocytopenia2010 Member, University of Utah Hospitals and Clinics, Computer Physician Order

Entry Protocol Development Committee2012 - 2014 Member, University of Utah Hospitals and Clinics, Data Safey Monitoring Board

for PerMIT II (Personalized Medicine Interface Tool): A Randomized Clinical Trial

College Level2000 - 2001 Senator, School of Medicine2001 Delegate, School of Medicine, American Foundation of Medical Research,

Western Regional Conference2001 - 2002 Council Member, School of Medicine, College Council

Department Level2002 - 2003 Chairperson, Internal Medicine, Student Advisory Committee2005 - 2007 Representative, Internal Medicine, Graduate Medical Education2007 - 2010 Peer Reviewer & Contributor, Internal Medicine, Thrombosis Watch Journal Club

Programs, Centers & Institutes2013 - 2016 Committee Member, MD/PhD Program2013 Faculty Advisor, Howard Hughes Medical Institute Med Into Grad Program2018 - Present Member, Program in Personalized Health Care, Faculty Advisory Committee

CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIESAmerican Association of ImmunologistsAmerican College of PhysiciansAmerican Geriatrics SocietyAmerican Heart AssociationAmerican Society of HematologyAnticoagulation ForumCouncil on Arteriosclerosis, Thrombosis, and Vascular BiologyInternational Society on Thrombosis and HaemostasisNorth American Thrombosis Forum

FUNDING

Active Grants

Rondina, Page 5

06/01/14 - 05/31/19 Platelet Immune Responses in Aging and InfluenzaR01 AG048022 Principal Investigator: Matthew T. Rondina National Institute on Aging Role: Principal Investigator

01/01/15 - 12/31/19 ASTRO-APS: Apixaban for the Secondary prevention of Thromboembolism: Aprospective Randomized Outcome pilot study among patients with the AntiphosPholipid Syndrome Bristol-Myers Squibb Role: Co-Investigator

07/01/16 - 06/30/21 New Therapies to Restore Vascular Integrity During SepsisR01 HL130541 National Heart, Lung, and Blood Institute Role: Co-Investigator

11/01/17 - 10/31/18 Epigenetic regulation of innate lymphocyte suppression in human andexperimental sepsis Principal Investigator(s): J. Scott Hale; Daniel T. Leung; Matthew T. Rondina University of Utah Immunology, Inflammation, and Infectious Diseases Initiative Role: Co-Principal Investigator

03/30/18 - 02/28/23 University of Utah Center for Clinical and Translational Science (CCTS)U54 TR002355 National Center for Advancing Translational Sciences Role: Co-Investigator

04/01/18 - 03/31/23 Platelet Reprogramming During InflammationI01 CX001696 Principal Investigator: Matthew T. Rondina Veterans Affairs Merit Review Award Role: Principal Investigator

05/01/18 - 01/31/19 Cellular Diagnostics in Sepsis Principal Investigator: Matthew T. Rondina Direct Costs: $43,956 Total Costs: $60,000 Recursion Pharmaceuticals LLC Role: Principal Investigator

07/01/18 - 06/30/22 Translational Control of Megakaryocyte and Platelet Function in SepsisR01 HL142804 Principal Investigator(s): Matthew T. Rondina; Andrew S. Weyrich Direct Costs: $250,000 Total Costs: $381,250 National Heart Lung & Blood Institute Role: Co-Principal Investigator

07/01/18 - 06/30/23 OPA1: An Estrogen-Mediated Modulator of Platelet HyperactivationR01 HL141783 Principal Investigator: Evan Dale Abel National Heart, Lung, and Blood Institute Role: Co-Investigator

Rondina, Page 6

09/01/18 - 08/31/21 Understanding Relationship Ambivalence and Its Links to Cardiovascular HealthR01 HL137606 Principal Investigator: Bert Uchino National Heart, Lung, and Blood Institute Role: Co-Investigator

Pending Grants07/01/18 - 06/30/19 Va Rondina-Platelet-Campbell

Principal Investigator: Matthew T. Rondina VA Salt Lake City Health Care System Role: Principal Investigator

07/01/18 - 06/30/23 The role of sepsis-induced platelet IFITM3 in thrombosis during agingK01 AG059892 Principal Investigator: Robert A. Campbell NIH National Institute of Aging Role: Mentor

07/01/18 - 06/30/23 Novel Regulatory Mechanisms of Sepsis Associated ThrombosisR01 AG059877 Principal Investigator: Matthew T. Rondina National Heart Lung & Blood Institute Role: Principal Investigator

09/01/18 - 08/31/23 Mucosal-associated invariant T (Mait) Cells In SepsisR01 GM130740 Principal Investigator(s): Daniel T. Leung; Matthew T. Rondina National Institutes of Health Role: Co-Principal Investigator

Past Grants01/01/96 - 12/31/98 Cortical Necrosis During Orthopedic Surgery

Bioscience Grant Principal Investigator: Matthew T. Rondina University of Utah Role: Principal Investigator

11/16/98 - 08/15/99 Integrated Information Technologies for Emergency Medical Care, NLM 99-NHAAP/VMS: Informatics for the National Heart Attack Alert Program(NHAAP), Phase 1 (Planning) National Institutes of Health Role: Co-Investigator

01/01/00 - 12/31/01 The Development of a Pediatric Stroke Registry Principal Investigator: Matthew T. Rondina American Heart Association Role: Principal Investigator

06/01/00 - 08/31/01 Degradation of Cyclooxygenase-2 Protein in Colon Cancer Cell Lines Principal Investigator: Matthew T. Rondina Kaplan, Inc. Role: Principal Investigator

Rondina, Page 7

09/30/00 - 09/29/03 Integrated Information Technologies for Emergency Medical Care, N01-LM-0-3524 Informatics for the National Heart Attack Alert Program (NHAAP), Phase2 (Feasibility) National Institutes of Health Role: Co-Investigator

04/01/02 - 10/01/02 Standard Fluoroscopy Versus Stereotactic Fluoroscopy for the In VitroPlacement of Thoracic Pedicle Screws Principal Investigator: Matthew T. Rondina Alpha Omega Alpha Honor Medical Society Role: Principal Investigator

03/01/05 - 03/01/06 The Development of Tolerance to Alpha 1-adrenceptor Blockade with ChronicCarvedilol TreatmentInvestigator-Award Principal Investigator: Edward Michael Gilbert GlaxoSmithKline Role: Co-Investigator

07/01/06 - 07/31/10 The Role of FDG-PET in Cancer Associated Venous ThromboembolismRO1 CA121003 Principal Investigator: Kathryn A. Morton National Cancer Institute Role: Co-Investigator

10/01/06 - 09/30/08 New Pathways to Coagulation in Thrombotic and Inflammatory DiseasesCatalyst Grant Principal Investigator: Andrew S. Weyrich University of Utah Health Sciences Role: Co-Investigator

05/01/07 - 05/01/08 VTE Prevention in the Morbidly Obese Medically Ill Patients: A PharmacologicalAnalysis of the Predictability of Prophylactic Weight-Based Enoxaparin Dosing.Investigator Initiated Award Principal Investigator: Robert C. Pendleton Sanofi-Aventis Role: Co-Investigator

06/01/07 - 06/01/08 The Effects of Calcitriol (1a, 25-[OH]2 Vitamin D3) on Renin Expression inHypertensive Patients without Vitamin D Deficiency American Foundation for Pharmaceutical Education Role: Co-Investigator

08/16/07 - 07/31/13 PerMIT: Warfarin (Personalized Medicine Interface Tool) II ProspectiveRandomized Controlled TrialR44 HL090055 National Heart, Lung, and Blood Institute Role: Co-Investigator, University of Utah

09/20/07 - 07/31/12 Novel Thrombotic and Inflammatory Mechanisms of Venous Thromboembolismin the ElderlyRO1 HL092746 Principal Investigator(s): Andrew S. Weyrich; Guy A. Zimmerman National Institutes of Health Role: Co-Investigator

Rondina, Page 8

02/01/08 - 01/31/13 Novel Activitities of Platelets in Acute Lung InjuryRO1 HL091754 Principal Investigator: Andrew S. Weyrich National Heart, Lung, and Blood Institute Role: Co-Investigator

11/01/08 - 06/30/09 Novel Platelet Functions in Sepsis and Venous Thromboembolism.University of Utah K12 Scholars Grant Principal Investigator: Matthew T. Rondina University of Utah Role: Principal Investigator

11/01/08 - 10/30/09 Prospective Characterization of Endogenous, Reverse Transcriptase Activity andPlatelet Proliferation in Severe SepsisUniversity of Utah CCTS Grant Principal Investigator(s): Matthew T. Rondina; Hansjorg Schwertz University of Utah Role: Principal Investigator

11/11/08 - 12/31/09 The Effects of Linezolid and Vancomycin in Inflammation and Cellular SignalingEventsInvestigator Initiated Award: GA5951 WK Principal Investigator: Matthew T. Rondina Pfizer, Inc. Role: Principal Investigator

05/01/09 - 12/31/12 TOPCOAT: Randomized Trial of Tenecteplase to Treat Patients with SevereSubmassive Pulmonary Embolism. (Carolinas Medical Center) Principal Investigator: Jeff Kline National Heart, Lung, and Blood Institute Role: Site Principal Investigator, University of Utah

07/01/09 - 05/31/14 Novel Platelet Functions in Sepsis and Venous ThromboembolismK23 HL092161 Principal Investigator: Matthew T. Rondina National Heart, Lung, and Blood Institute Role: Principal Investigator

07/01/10 - 06/30/11 Multiplexed Biomarker Assays in Antiphospholipid Antibody Syndrome Principal Investigator: D. Ware Branch National Heart, Lung, and Blood Institute Role: Co-Investigator

08/15/11 - 07/31/13 The Regulation of Inflammatory Gene Responses in AgingR03 AG040631 Principal Investigator: Matthew T. Rondina National Institutes of Health Role: Principal Investigator

04/01/12 - 04/30/18 Reprogrammed Platelets: Effectors of Thrombosis in Metabolic SyndromesU54 HL1123 Principal Investigator: Andrew S. Weyrich National Heart, Lung, and Blood Institute Role: Co-Investigator, Project 3 and Core B Lead

Rondina, Page 9

01/01/14 - 12/31/14 Platelets: Unexamined Contributors to ImmunosenescencePilot Grant Program Principal Investigator: Matthew T. Rondina University of Utah Center on Aging Role: Principal Investigator

05/01/14 - 04/30/16 Systems Biology Approach to Cognitive Impairment after Septic Shock Principal Investigator: Samuel M. Brown Intermountain Research and Medical Foundation Role: Co-Investigator

06/01/14 - 05/31/15 Thrombo-Inflammation and Statins in Elderly, Orthopedic Surgery Patients Principal Investigator: Bass Weill Cornell Medical College Clinical & Translational Science Center Role: Co-Investigator

06/01/14 - 05/31/15 CTSC Pilot Study (Subcontract)UL1 TR000457 National Center for Advancing Translational Sciences Role: Co-Investigator/Site-Lead

09/15/14 - 06/30/18 The Effects of ART on Platelets and HIV-Associated ThrombosisR01 HL126547 Principal Investigator(s): Matthew T. Rondina; Andrew S. Weyrich National Heart, Lung, and Blood Institute Role: Co-Principal Investigator

01/01/15 - 12/31/15 Qinghai High - Altitude Research ProgramPlatelet Contributions to High-Altitude and Hypoxia Chinese Central Government Role: Scientific Advisor

05/01/15 - 04/30/18 University of Utah Center for Clinical and Translational Science (CCTS)UL1 TR001067 National Center for Advancing Translational Sciences Role: Co-Investigator

07/01/17 - 06/30/18 Role of Metformin on Muscle and Metabolic Function in Older Adults After BedRest Principal Investigator: Micah J. Drummond University of Utah Center on Aging Role: Co-Investigator

TEACHING RESPONSIBILITIES/ASSIGNMENTS

Course and Curriculum Development2008 - 2012 Geriatric Inpatient Core Curriculum2009 - 2016 INTMD Course 7920, Topics in Thrombosis

Courses Directed2007 - 2009 University Healthcare Thrombosis Symposium, University of Utah2007 - 2010 University Healthcare Thrombosis Service Quarterly Conference2009 - 2016 INTMD Course 7920, Topics in Thrombosis

Course LecturesRondina, Page 10

1999 Teaching Assistant, University of Utah. Chemistry Course2002 - 2003 Assistant Instructor, Physical Diagnosis Course, University of Utah. Medical

School2009 - 2014 Faculty Instructor, University of Utah. Heparin-Induced Thrombocytopenia2013 Instructor (1): MS2016 MCC - Transfusions, University of Utah2013 Primary Instructor, INTMD 7920 (1): Topics in Thrombosis, 4 SCH, 1 student,

University of Utah, Internal Medicine2014 Primary Instructor, INTMD 7920 (1): Topics in Thrombosis, 2 SCH, 1 student,

University of Utah, Internal Medicine2015 - Present INTMD: Molecular Medicine (Med-to-Grad) Thrombosis & Hemostasis,

University of Utah, Internal Medicine2016 Instructor, Topics in Inflammation, University of Puerto Rico

Clinical Teaching2007 - 2014 Teaching Attending, University of Utah Inpatient Wards2014 Faculty Educator, Moi Teaching Referral and Hospital, Eldoret, Kenya2018 Geriatrics Fellow Board Review on Thrombosis and Pulmonary Embolism,

University of Utah

Trainee SupervisionFaculty2009 - 2012 Advisor/Mentor, Andrew Freeman, University of Utah. Focus of Project:

Development of a Weight-Based Enoxaparin Dosing Algorithm to PreventVTE in Morbidly Obese PatientsTrainee's Current Career Activities: Fellow, University of Utah

2012 - 2013 Advisor/Mentor, Peter Yarbrough, University of Utah. Focus of Project:Argatroban Dosing in Heparin-Induced Thrombocytopenia and AdvancedLiver DiseaseTrainee's Current Career Activities: Associate Professor, George E. WahlenVAMC

2012 - 2013 Mentor, Mark Mulcaire-Jones, University of Utah. Focus of Project: Fibrinogenas a Novel Risk Factor for Thrombosis in Critically-Ill PatientsTrainee's Current Career Activities: Internal Medicine Physician, New Zealand

2014 - 2015 Advisor/Mentor, Devin Horton, University of Utah. Focus of Project: Rivaroxabanfor the Treatment of Spontaneous Ovarian Vein ThrombosisTrainee's Current Career Activities: Assistant Professor, University of Utah

2014 - 2016 Advisor/Mentor, David Kaplan, University of Utah. Focus of Project: VenousThromboembolism in Critical IllnessTrainee's Current Career Activities: Associate Professor, University of Utah

2015 - Present Advisor/Mentor, Rashmee Shah, University of Utah. Focus of Project: ThePrevention of Thrombosis in AF, *VPCAT Scholar, *2017 Next Gen InnovatorAward, *K08 HL136850Trainee's Current Career Activities: Assistant Professor, University of Utah

2017 - Present Advisor/Mentor, Homam Ibrahim, University of Utah. Focus of Project: Plateletsand CVD *VPCAT ScholarTrainee's Current Career Activities: Assistant Professor, University of Utah

Rondina, Page 11

2017 - Present Advisor/Mentor, Elizabeth Middleton, University of Utah. Focus of Project:Platelets and Sepsis *Academic Excellence Seed Grant Awardee, *Society ofCritical Care Medicine Silver Snapshot AwardTrainee's Current Career Activities: Assistant Professor, University of Utah

2017 - Present Advisor/Mentor, Pavel Davizon-Castillo, University of Utah. Focus of Project:Platelet activation in inflammation and aging *2018 ASH Research FellowAwardTrainee's Current Career Activities: Instructor, University of Colorado

2017 - Present Advisor/Mentor, Jesse Rowley, University of Utah. Focus of Project: Plateletsand Metabolism, *K01 GM103806, *R01 HL144957Trainee's Current Career Activities: Assistant Professor, University of Utah

Fellow2009 - Present Advisor/Mentor, Robert Campbell, University of Utah. Focus of Project: Platelets

and Inflammation *2017 StrokeNet Scholar Fellowship, *2017 VPCAT Scholar,*2018 Kenneth M. Brinkhous Young Investigator Prize in ThrombosisTrainee's Current Career Activities: Assistant Professor, University of Utah

2012 - 2015 Advisor/Mentor, McKenzie Carlisle, University of Utah. Focus of Project:Platelets in Metabolic Syndromes, *NIH LRP AwardeeTrainee's Current Career Activities: Research Program Manager, BioFire

2013 - 2014 Advisor/Mentor, Antigone Koliopoulou, University of Utah. Focus of Project:Platelet Reprogramming in Heart Failure *Fellowship GrantTrainee's Current Career Activities: Assistant Professor, University of Utah

2013 - 2015 Advisor/Mentor, Danielle Nance, University of Utah. Focus of Project: CouplingDNA and RNA Sequencing to Identify and Characterize Inherited PlateletDisorders, *NIH LRP Awardee Trainee's Current Career Activities: Assistant Professor, Division ofHematology, University of Arizona

2015 - Present Advisor/Mentor, Bhanu Kanth Manne, University of Utah. Focus of Project:Genetic Reprogramming in Platelets, *ASH 2016 Travel Award, *ATVB 2017Travel Award, *2018 AHA Postdoctoral Fellowship AwardTrainee's Current Career Activities: Research Associate, University of Utah

2017 - Present Advisor/Mentor, Frederik Denorme, University of Utah. Focus of Project:Platelets, Stoke, and Inflammation, *Belgium Fellowship AwardeeTrainee's Current Career Activities: Post-Doctoral Fellow, University of Lueven,Belgium

Resident2012 - 2013 Advisor/Mentor, Rhett Cook, University of Utah. Focus of Project: Venous

Thromboembolism in SepsisTrainee's Current Career Activities: Internal Medicine Physician, Salt Lake City,Utah

PhD/Doctorate2008 - 2009 Mentor, Sarah Vazquez, University of Utah. Focus of Project: Peri-procedural

Anticoagulation in Atrial Fibrillation, *NATF Fellowship AwardTrainee's Current Career Activities: Pharm. D., Anticoagulation Pharmacist,University of Utah

Rondina, Page 12

2016 - Present Advisor/Mentor, Amily Guo, University of Utah. Focus of Project: Aging andPlateletsTrainee's Current Career Activities: Post-Doctoral Fellow, University of Utah

2017 - Present Advisor/Mentor, Alec McKenzie, University of Utah. Focus of Project: Aging andMetabolism, *F31 AG059438Trainee's Current Career Activities: PhD Candidate, University of Utah

MD, PhD2013 - 2014 Advisor/Mentor, Charles Langelier, University of Utah. Focus of Project: Platelets

and Acute Lung Injury, * UCSF KL2 Awardee, *K23 AwardeeTrainee's Current Career Activities: Assistant Professor, UCSF

2014 - 2015 Advisor/Mentor, Yan-Xia Shao, University of Utah. Focus of Project: VascularEndothelial Function in HypoxiaTrainee's Current Career Activities: Assistant Professor, Qinghai University,China

2014 - 2016 Advisor/Mentor, Jin Xu, University of Utah. Focus of Project: Genetic Variantsand HAPETrainee's Current Career Activities: PhD Candidate, Qinghai University, China

2015 - Present Advisor/Mentor, Chun Xiang Shang, University of Utah. Focus of Project:Platelets and Lung InjuryTrainee's Current Career Activities: PhD Candidate, Qinghai University, China

2015 - Present Advisor/Mentor, Jessica Morales, University of Utah. Focus of Project: Platelet-Neutrophils in Health and Disease, *F31 HL136183, *2017 THSNA TravelAwardTrainee's Current Career Activities: Graduate Student, University of Puerto Rico

Medical Student2008 - 2009 Advisor/Mentor, Ryan Vanwoerkom, University of Utah. Focus of Project: The

Post-Thrombotic Syndrome as a Complication of Venous ThromboembolismTrainee's Current Career Activities: Internal Medicine Physician, Scottsdale, AZ

2009 - 2012 Advisor/Mentor, Zechariah Franks, University of Utah. Focus of Project: Plateletsand InfectionTrainee's Current Career Activities: ENT Resident, Johns Hopkins University

2011 - 2012 Advisor/Mentor, Amer Varedi, University of Utah. Focus of Project: Heparin-Induced ThrombocytopeniaTrainee's Current Career Activities: Surgical Residency, Yale

2012 - 2013 Advisor/Mentor, Ryan Ernst, University of Utah. Focus of Project: PlateletActivation in Acute Lung InjuryTrainee's Current Career Activities: Emergency Medicine Resident, OHSU

2012 Advisor/Mentor, Marina De Amorim, University of Utah. Focus of Project:Platelet and Pro-Coagulant Functions in ObesityTrainee's Current Career Activities: Physician, Miami, Florida

2013 Advisor/Mentor, Donya Mohabeli, University of Utah. Focus of Project: PlateletFunctions in AgingTrainee's Current Career Activities: Clinical Fellow in Medicine, Beth IsraelDeaconess Medical Center

Rondina, Page 13

2013 Advisor/Mentor, Tagrid Ruiz, University of Utah. Focus of Project: PlateletImmune Responses During Viral Infectivity in MegakaryocytesTrainee's Current Career Activities: Obstetrics/Gynecology Resident, Universityof Utah

2013 - 2014 Advisor/Mentor, Manpreet Kaur, University of Utah. Focus of Project: PlateletActivities in SepsisTrainee's Current Career Activities: Physician, Uintah Basin Healthcare, Utah

2014 - 2015 Advisor/Mentor, Lauren Shih, University of Utah. Focus of Project: DysregulatedPlatelet Functions in Frailty and Aging *MSTAR AwardeeTrainee's Current Career Activities: Internal Medicine Resident, University ofWashington

2015 - 2016 Advisor/Mentor, Ryan Watkins, University of Utah. Focus of Project: PlateletMitochondria and Infection, *NHLBI T35 AwardeeTrainee's Current Career Activities: Medical Student, University of Utah

2015 - 2017 Advisor/Mentor, Anish Bhatnagar, University of Utah. Focus of Project: Platelet-Monocyte Interactions in Aging, *NHLBI T35 AwardeeTrainee's Current Career Activities: Ophthalmology Resident, Beth IsraelDeaconess Medical Center

2015 - Present Advisor/Mentor, Travis Griffiths, University of Utah. Focus of Project: Platelets inSepsis, *NHLBI T35 AwardeeTrainee's Current Career Activities: Medical Student, University of Utah

2015 - Present Advisor/Mentor, Alicia Eustes, University of Utah. Focus of Project: TranslationalControl Mechanisms in PlateletsTrainee's Current Career Activities: PhD Candidate, University of Utah

2016 Advisor/Mentor, Kelly Hoerger, University of Utah. Focus of Project: Platelets inMetabolic Disorders, *NIDDK T35 AwardeeTrainee's Current Career Activities: Medical Student, University of Utah

2016 - 2017 Advisor/Mentor, Miles Christensen, University of Utah. Focus of Project: Plateletsin Aging, *NHLBI T35 AwardeeTrainee's Current Career Activities: Medical Student, University of Utah

2016 - 2017 Advisor/Mentor, Paul Crane, University of Utah. Focus of Project: Platelets inSepsis, *NHLBI T35 AwardeeTrainee's Current Career Activities: Medical Student, University of Utah

2017 Advisor/Mentor, Lauren Page, University of Utah. Focus of Project: Platelets andInflammation, *NHLBI T35 AwardeeTrainee's Current Career Activities: Medical Student, University of Utah

2017 - Present Advisor/Mentor, Ben Berger, University of Utah. Focus of Project: Platelet-Endothelial Cell Interactions in Inflammatory Vasculitis, *NHLBI T35AwardeeTrainee's Current Career Activities: Medical Student, University of Utah

2017 - Present Advisor/Mentor, Kyra McCormas, University of Utah. Focus of Project: PlateletImmune Responses in Sepsis, *NHLBI T35 Awardee, *Recipient of the 2018James A. Bush Memorial Research AwardTrainee's Current Career Activities: Medical Student, University of Utah

Undergraduate

Rondina, Page 14

2011 - 2013 Advisor/Mentor, BreAnna Brewster, University of Utah. Undergraduate ResearchOpportunities Program (UROP). Focus of Project: Obesity-Induced Platelet andLeukocyte Activation Promotes Thrombosis & Platelet Activation in H1N1Influenza, *UROP AwardTrainee's Current Career Activities: Graduate Student

2014 - 2015 Advisor/Mentor, Sarah Mereby, University of Utah. Focus of Project: PlateletImmune ActivitiesTrainee's Current Career Activities: PhD Graduate, Emory University ResearchScientist, Memorial Sloan Kettering Cancer Center

Educational Lectures

Department/Division Conferences2010 Faculty Member, Hospital Medicine Annual Meeting, University of Utah2010 Chair, Research Working Group, University of Utah Western Regional

Thrombosis Symposium

Other Educational Activities2011 Invited Facilitator, Thematic Poster Session "Pulmonary Embolism." American

Thoracic Society National Meeting. Denver, Colorado

PEER-REVIEWED JOURNAL ARTICLES1. Bachus KN, Rondina MT, Hutchinson DT (2000). The effects of drilling force on cortical

temperatures and their duration: an in vitro study. Med Eng Phys, 22(10), 685-91.2. Rao G, Brodke DS, Rondina M, Dailey AT (2002). Comparison of computerized tomography and

direct visualization in thoracic pedicle screw placement. J Neurosurg, 97(2 Suppl), 223-6.3. Rao G, Brodke DS, Rondina M, Bacchus K, Dailey AT (2003). Inter- and intraobserver reliability

of computed tomography in assessment of thoracic pedicle screw placement. Spine, 28(22), 2527-30.

4. Dailey AT, Rondina MT, Townsend JJ, Shrieve DC, Baringer JR, Moore KR (2004). Sciatic nervesarcoidosis: utility of magnetic resonance peripheral nerve imaging and treatment with radiationtherapy. J Neurosurg, 100(5), 956-9.

5. Rondina MT, Muhlestein JB (2005). Early initiation of statin therapy in acute coronary syndromes:a review of the evidence. J Interv Cardiol, 18(1), 55-63.

6. Rondina MT (2005). Compression ultrasound for DVT. Resid Staff Physician.7. Rondina MT, Zebrak JS (2005). Achieving National Cholesterol Education Program goals in

coronary artery disease. Preventive Cardiology, 8(1), 18-22.8. Rondina MT, Raphael K, Pendleton R, Sande MA (2006). Abdominal aortitis due to Streptococcus

pneumoniae and Enterobacter aerogenes: a case report and review. J Gen Intern Med, 21(7), C1-3.

9. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, RondinaMT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS (2006). Signal-dependentsplicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med,203(11), 2433-40.

10. Rondina MT, Pendleton RC, Wheeler M, Rodgers GM (2007). The treatment of venousthromboembolism in special populations. Thromb Res, 119(4), 391-402.

Rondina, Page 15

11. Rondina MT, Markewitz B, Kling SJ, Nohavec R, Rodgers GM (2007). The accuracy of activatedpartial thromboplastin times when drawn through a peripherally inserted central catheter. Am JHematol, 82(8), 738-9.

12. Rondina MT, Lappe JM, Carlquist JF, Muhlestein JB, Kolek MJ, Horne BD, Pearson RR,Anderson JL (2008). Soluble CD40 ligand in predicting coronary artery disease and long-termoutcomes in stable patients with angiographically defined disease states. Cardiology, 109(3), 196-201.

13. Vazquez SR, Rondina MT, Pendleton RC (2008). Azathioprine-induced warfarin resistance. AnnPharmacother, 42(7), 1118-23.

14. Van Tassell BW, Rondina MT, Huggins F, Gilbert EM, Munger MA (2008). Carvedilol increasesblood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction:evidence of improved vascular alpha1-adrenoreceptor signal transduction. Am Heart J, 156(2), 315-21.

15. Rondina MT, Fang JC, Yu M (2008). Episodic fevers as a novel feature of the carcinoidsyndrome. Am J Clin Oncol, 31(6), 623.

16. Pendleton RC, Rondina MT, Wheeler M, Rodgers GM (2009). The longitudinal effects of amultifaceted quality improvement intervention to improve venous thromboembolism preventionpersist over time. Open Gen Intern Med J, 3, 20-24.

17. Rondina MT (2009). Oral vitamin K did not reduce bleeding in patients with excessiveanticoagulation after receiving warfarin. Ann Intern Med, 150(12), JC6-9.

18. Vazquez SR, Freeman A, VanWoerkom RC, Rondina MT (2009). Contemporary issues in theprevention and management of postthrombotic syndrome. Ann Pharmacother, 43(11), 1824-35.

19. Rondina MT, Wheeler M, Rodgers GM, Draper L, Pendleton RC (2010). Weight-based dosing ofenoxaparin for VTE prophylaxis in morbidly obese, medically-ill patients. Thromb Res, 125(3), 220-223.

20. Rondina MT, Walker A, Pendleton RC (2010). Drug-induced thrombocytopenia for the hospitalistphysician with a focus on heparin-induced thrombocytopenia. Hosp Pract (1995), 38(2), 19-28.

21. Vazquez SR, Johnson SA, Rondina MT (2010). Peri-procedural anticoagulation in patientsundergoing ablation for atrial fibrillation. Thromb Res, 126(2), e69-77.

22. Franks ZG, Campbell RA, Weyrich AS, Rondina MT (2010). Platelet-leukocyte interactions linkinflammatory and thromboembolic events in ischemic stroke. Ann N Y Acad Sci, 1207, 11-7.

23. Freeman AL, Pendleton RC, Rondina MT (2010). Prevention of venous thromboembolism inobesity. Expert Rev Cardiovasc Ther, 8(12), 1711-21.

24. Vazquez S, Rondina MT (2010). ACP Journal Club. Review: Graduated compression stockingsreduce deep venous thrombosis in hospitalized patients. Ann Intern Med, 153(12), JC6-6.

25. Johnson S, Rondina MT (2011). Local INR control had some effect on the benefits of dabigatranover warfarin for major bleeding in atrial fibrillation. ACP J Club, 154(2), JC1-6.

26. Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, Mackman N, Grissom CK,Weyrich AS, Zimmerman GA (2011). The septic milieu triggers expression of spliced tissue factormRNA in human platelets. J Thromb Haemost, 9(4), 748-58.

27. Rondina MT, Wanner N, Pendleton RC, Kraiss LW, Vinik R, Zimmerman GA, Heilbrun M,Hoffman JM, Morton KA (2011). A pilot study utilizing whole body 18 F-FDG-PET/CT as acomprehensive screening strategy for occult malignancy in patients with unprovoked venousthromboembolism. Thromb Res, 129(1), 22-7.

28. Rondina MT, Grissom CK, Men S, Harris ES, Schwertz H, Zimmerman GA, Weyrich AS (2012).Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients areinfluenced by variability in blood sampling techniques. Thromb Res, 129(6), 729-35.

Rondina, Page 16

29. Rondina MT, Brewster B, Grissom CK, Zimmerman GA, Kastendieck DH, Harris ES, WeyrichAS (2012). In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1).Chest, 141(6), 1490-1495.

30. Freeman A, Horner T, Pendleton RC, Rondina MT (2012). Prospective comparison of threeenoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically illpatients with extreme obesity. Am J Hematol, 87(7), 740-3.

31. McInturff AM, Cody MJ, Elliott EA, Glenn JW, Rowley JW, Rondina MT, Yost CC (2012).Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction ofhypoxia-inducible factor 1 alpha. Blood, 120(15), 3118-25.

32. Yarbrough PM, Varedi A, Walker A, Rondina MT (2012). Argatroban dose reductions forsuspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease. AnnPharmacother, 46(11), e30.

33. Rondina MT, Lam UT, Pendleton RC, Kraiss LW, Wanner N, Zimmerman GA, Hoffman JM,Hanrahan C, Boucher K, Christian PE, Butterfield RI, Morton KA (2012). (18)F-FDG PET in theevaluation of acuity of deep vein thrombosis. Clin Nucl Med, 37(12), 1139-45.

34. Kraemer BF, Campbell RA, Schwertz H, Franks ZG, Vieira de Abreu A, Grundler K, Kile BT,Dhakal BK, Rondina MT, Kahr WH, Mulvey MA, Blaylock RC, Zimmerman GA, Weyrich AS(2012). Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets.Blood, 120(25), 5014-20.

35. Chen K, Rondina MT, Weyrich AS (2013). A sticky story for signal transducer and activator oftranscription 3 in platelets. Circulation, 127(4), 421-3.

36. Rondina MT, Weyrich AS, Zimmerman GA (2013 May 24). Platelets as cellular effectors ofinflammation in vascular disease. Circ Res, 112(11), 1506-19.

37. Franks Z, Campbell RA, Vieira de Abreu A, Holloway JT, Marvin JE, Kraemer BF, ZimmermanGA, Weyrich AS, Rondina MT (2013). Methicillin-resistant Staphylococcus aureus-inducedthrombo-inflammatory response is reduced with timely antibiotic administration. Thromb Haemost,109(4), 684-95.

38. Vazquez S, Rondina MT (2013). ACP Journal Club. Apixaban reduced stroke or systemicembolism in AF more than warfarin regardless of type or duration of AF. Ann Intern Med, 159(2),JC8.

39. Rondina MT, Weyrich AS, Zimmerman GA (2013). Reply to Schattner. Circ Res, 113(9), e93.40. Brown SM, Tate Q, Jones JP, Knox DB, Kuttler KG, Lanspa M, Rondina MT, Grissom CK,

Behera S, Mathews VJ, Morris A (2013). Initial fractal exponent of heart rate variability isassociated with success of early resuscitation in patients with severe sepsis or septic shock: aprospective cohort study. J Crit Care, 28(6), 959-63.

41. Kline JA, Hernandez J, Hogg MM, Jones AE, Courtney DM, Kabrhel C, Nordenholz KE, DiercksDB, Rondina MT, Klinger JR (2013). Rationale and methodology for a multicentre randomised trialof fibrinolysis for pulmonary embolism that includes quality of life outcomes. Emerg Med Australas,25(6), 515-26.

Rondina, Page 17

42. Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS,Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC,Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, OrtelTL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM,Ellenberg JH, COAG Investigators:, Rondina M, et. al (2013). A Pharmacogenetic Versus AClinical Algorithm For Warfarin Dosing. N Engl J Med, 369(24), 2283-93.

43. Rondina MT, Garraud O (2014). Emerging evidence for platelets as immune and inflammatoryeffector cells. Front Immunol, 5, 653.

44. Mohebali D, Kaplan D, Carlisle M, Supiano MA, Rondina MT (2014). Alterations in plateletfunction during aging: clinical correlations with thromboinflammatory disease in older adults. J AmGeriatr Soc, 62(3), 529-35.

45. Vo TL, Cook RM, Rondina MT, Kaplan D (2014). Cerebral venous sinus thrombosis in the settingof combined vaginal contraception. Blood Coagul Fibrinolysis, 25(2), 183-5.

46. Vo T, Vazquez S, Rondina MT (2014). Current state of anticoagulants to treat deep venousthrombosis. Curr Cardiol Rep, 16(3), 463.

47. Johnson SA, Rondina MT (2014). Edoxaban was noninferior to warfarin for preventing stroke orsystemic embolism in atrial fibrillation. Ann Intern Med, 160(6), JC7.

48. Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, KlingerJR, Hernandez J (2014). Treatment of submassive pulmonary embolism with tenecteplase orplacebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlledrandomized trial. J Thromb Haemost, 12(4), 459-68.

49. Rondina MT, Carlisle M, Fraughton T, Brown SM, Miller RR 3rd, Harris ES, Weyrich AS,Zimmerman GA, Supiano MA, Grissom CK (2014). Platelet-Monocyte Aggregate Formation andMortality Risk in Older Patients With Severe Sepsis and Septic Shock. J Gerontol A Biol Sci MedSci, 70(2), 225-231.

50. Cook RM, Rondina MT, Horton DJ (2014). Rivaroxaban for the Long-term Treatment ofSpontaneous Ovarian Vein Thrombosis Caused by Factor V Leiden Homozygosity. AnnPharmacother, 48(8), 1055-1060.

51. Madden JL, Drakos SG, Stehlik J, McKellar SH, Rondina MT, Weyrich AS, Selzman CH (2014).Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis.ASAIO J, 60(5), 524-8.

52. Rondina M (2014). In nonvalvular atrial fibrillation, effects of rivaroxaban compared with warfarindid not differ by patient age. Ann Intern Med, 161(10), JC5.

53. Zhao YX, Tang F, Ga Q, Wuren T, Wang YP, Rondina MT, Ge RL (2015). High fat dietexacerbates vascular endothelial dysfunction in rats exposed to continuous hypobaric hypoxia.Biochem Biophys Res Commun, 457(3), 485-91.

54. Edholm K, Ragle N, Rondina MT (2015). Antithrombotic management of atrial fibrillation in theelderly. Med Clin North Am, 99(2), 417-30.

55. Franks Z, Carlisle M, Rondina MT (2015). Current challenges in understanding immune cellfunctions during septic syndromes. BMC Immunol, 16, 11.

56. Brown SM, Grissom CK, Rondina MT, Hoidal JR, Scholand MB, Wolff RK, Morris AH, Paine R3rd (2015). Polymorphisms in key pulmonary inflammatory pathways and the development of acuterespiratory distress syndrome. Exp Lung Res, 41(3), 155-62.

57. Buitrago L, Rendon A, Liang Y, Simeoni I, Negri A, ThromboGenomics Consortium, Rondina M, etal, Filizola M, Ouwehand WH, Coller BS (2015). αIIbβ3 variants defined by next-generationsequencing: predicting variants likely to cause Glanzmann thrombasthenia. Proc Natl Acad Sci U SA, 112(15), E1898-907.

Rondina, Page 18

58. Rondina MT, Weyrich AS (2015). Regulation of the genetic code in megakaryocytes and platelets.J Thromb Haemost, 13 Suppl 1, S26-32.

59. Rondina MT, Weyrich AS (2015). Dengue virus pirates human platelets. Blood, 126(3), 286-7.60. Xu J, Yang YZ, Tang F, Ga Q, Wuren T, Wang Z, Ma L, Rondina MT, Ge RL (2015). CYP17A1

and CYP2E1 variants associated with high altitude polycythemia in Tibetans at the Qinghai-TibetanPlateau. Gene, 566(2), 257-63.

61. Stewart LK, Peitz GW, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT,Diercks DB, Klinger JR, Kline JA (2015). Contribution of fibrinolysis to the physical componentsummary of the SF-36 after acute submassive pulmonary embolism. J Thromb Thrombolysis,40(2), 161-6.

62. Brown SM, Tate MQ, Jones JP, Kuttler KG, Lanspa MJ, Rondina MT, Grissom CK, Mathews VJ(2015). Coefficient of Variation of Coarsely Sampled Heart Rate is Associated With EarlyVasopressor Independence in Severe Sepsis and Septic Shock. J Intensive Care Med, 30(7), 420-5.

63. Watkins RD, Rondina MT (2015). ACP Journal Club. Review: DOACs do not differ fromstandard anticoagulants for recurrent VTE; factor Xa inhibitors reduce bleeding. Ann Intern Med,163(8), JC3.

64. Kaplan D, Casper TC, Elliott CG, Men S, Pendleton RC, Kraiss LW, Weyrich AS, Grissom CK,Zimmerman GA, Rondina MT (2015). VTE Incidence and Risk Factors in Patients With SevereSepsis and Septic Shock. Chest, 148(5), 1224-1230.

65. Su J, Li Z, Cui S, Ji L, Geng H, Chai K, Ma X, Bai Z, Yang Y, Wuren T, Ge RL, Rondina MT(2015). The Local HIF-2alpha/EPO Pathway in the Bone Marrow is Associated with ExcessiveErythrocytosis and the Increase in Bone Marrow Microvessel Density in Chronic MountainSickness. High Alt Med Biol, 16(4), 318-30.

66. Vazquez S, Rondina MT (2015). Direct oral anticoagulants (DOACs). Vasc Med, 20(6), 575-7.67. Shah RU, Rupp AB, Mowery D, Zhang M, Stoddard G, Deshmukh V, Bray BE, Hess R, Rondina

MT (2016). Changes in Oral Anticoagulant Treatment Rates in Atrial Fibrillation before and afterthe Introduction of Direct Oral Anticoagulants. Neuroepidemiology, 47(3-4), 201-209.

68. Stubblefield WB, Alves NJ, Rondina MT, Kline JA (2016). Variable Resistance to PlasminogenActivator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism. PLoS One, 11(2),e0148747.

69. Rondina MT, Graves KK (2016). The addition of abdomen and pelvis CT to limited cancerscreening does not increase diagnosis of cancer in patients with unprovoked venousthromboembolism. Evid Based Med, 21(1), 19.

70. Rondina MT, Weyrich AS (2016). Arf6 arbitrates fibrinogen endocytosis. Blood, 127(11), 1383-4.71. Woller SC, Stevens SM, Kaplan DA, Branch DW, Aston VT, Wilson EL, Gallo HM, Johnson EG,

Rondina MT, Lloyd JF, Evans RS, Elliott CG (2016). Apixaban for the Secondary Prevention ofThrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design(ASTRO-APS). Clin Appl Thromb Hemost, 22(3), 239-47.

72. Rondina MT, Freitag M, Pluthero FG, Kahr WH, Rowley JW, Kraiss LW, Franks Z, ZimmermanGA, Weyrich AS, Schwertz H (2016). Non-genomic activities of retinoic acid receptor alpha controlactin cytoskeletal events in human platelets. J Thromb Haemost, 14(5), 1082-94.

73. Koliopoulou A, McKellar SH, Rondina M, Selzman CH (2016). Bleeding and thrombosis in chronicventricular assist device therapy: focus on platelets. Curr Opin Cardiol, 31(3), 299-307.

74. Schwertz H, Rondina MT (2016 Jun). Cdkn2a Orchestrates Platelet Production and Reactivity inAtherosclerosis. Circ Cardiovasc Genet, 9(3), 203-5.

Rondina, Page 19

75. Shih L, Kaplan D, Kraiss LW, Casper TC, Pendleton RC, Peters CL, Supiano MA, ZimmermanGA, Weyrich AS, Rondina MT (2016). Platelet-Monocyte Aggregates and C-Reactive Protein areAssociated with VTE in Older Surgical Patients. Sci Rep, 6, 27478.

76. Simeoni I, Stephens JC, Hu F, Deevi SV, Megy K, Bariana TK, Lentaigne C, Schulman S,Sivapalaratnam S, Vries MJ, Westbury SK, Greene D, Papadia S, Alessi MC, Attwood AP,Ballmaier M, Baynam G, Bermejo E, Bertoli M, Bray PF, Bury L, Cattaneo M, Collins P, DaughertyLC, Favier R, French DL, Furie B, Gattens M, Germeshausen M, Ghevaert C, Goodeve AC,Guerrero JA, Hampshire DJ, Hart DP, Heemskerk JW, Henskens YM, Hill M, Hogg N, Jolley JD,Kahr WH, Kelly AM, Kerr R, Kostadima M, Kunishima S, Lambert MP, Liesner R, Lopez JA,Mapeta RP, Mathias M, Millar CM, Nathwani A, Neerman-Arbez M, Nurden AT, Nurden P,Othman M, Peerlinck K, Perry DJ, Poudel P, Reitsma P, Rondina MT, Smethurst PA, StevensonW, Szkotak A, Tuna S, van Geet C, Whitehorn D, Wilcox DA, Zhang B, Revel-Vilk S, Gresele P,Bellissimo DB, Penkett CJ, Laffan MA, Mumford AD, Rendon A, Gomez K, Freson K, OuwehandWH, Turro E (2016). A high-throughput sequencing test for diagnosing inherited bleeding,thrombotic, and platelet disorders. Blood, 127(23), 2791-803.

77. Rondina MT, Tatsumi K, Bastarache JA, Mackman N (2016). Microvesicle Tissue Factor Activityand Interleukin-8 Levels are Associated with Mortality in Patients with Influenza A/H1N1 Infection.Crit Care Med, 44(7), e574-8.

78. Johnson SA, Eleazer GP, Rondina MT (2016). Pathogenesis, Diagnosis, and Treatment of VenousThromboembolism in Older Adults. J Am Geriatr Soc, 64(9), 1869-78.

79. Yost CC, Schwertz H, Cody MJ, Wallace JA, Campbell RA, Vieira-de-Abreu A, Araujo CV,Schubert S, Harris ES, Rowley JW, Rondina MT, Fulcher JM, Koening CL, Weyrich AS,Zimmerman GA (2016). Neonatal NET-inhibitory factor and related peptides inhibit neutrophilextracellular trap formation. J Clin Invest, 126(10), 3783-3798.

80. Brown SM, Sorensen J, Lanspa MJ, Rondina MT, Grissom CK, Shahul S, Mathews VJ (2016).Multi-complexity measures of heart rate variability and the effect of vasopressor titration: aprospective cohort study of patients with septic shock. BMC Infect Dis, 16(1), 551.

81. Nance D, Campbell RA, Rowley JW, Downie JM, Jorde LB, Kahr WH, Mereby SA, Tolley ND,Zimmerman GA, Weyrich AS, Rondina MT (2016). Combined variants in factor VIII andprostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants. JThromb Haemost, 14(11), 2230-2240.

82. Kapur R, Kim M, Rondina MT, Porcelijn L, Semple JW (2016). Elevation of C-reactive proteinlevels in patients with transfusion-related acute lung injury. Oncotarget, 7(47), 78048-78054.

83. Middleton E, Rondina MT (2016). Platelets in infectious disease. Hematology Am Soc HematolEduc Program, 2016(1), 256-261.

84. Shih L, Guler N, Syed D, Hopkins W, McComas KN, Walborn A, Hoppensteadt D, Fareed J,Rondina MT (2017). Postoperative Changes in the Systemic Inflammatory Milieu in Older SurgicalPatients. Clin Appl Thromb Hemost, 1076029617747412.

85. Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, Megy K, Grozeva D, DewhurstE, Malka S, Plagnol V, Penkett C, Stirrups K, Rizzo R, Wright G, Josifova D, Bitner-Glindzicz M,Scott RH, Clement E, Allen L, Armstrong R, Brady AF, Carmichael J, Chitre M, Henderson RH,Hurst J, MacLaren RE, Murphy E, Paterson J, Rosser E, Thompson DA, Wakeling E, OuwehandWH, Michaelides M, Moore AT, NIHR-BioResource Rare Diseases Consortium, Rondina MT, etal (2017). Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine theMolecular Pathology of Inherited Retinal Disease. Am J Hum Genet, 100(1), 75-90.

86. Pannucci CJ, Rondina MT (2017). Should we be following anti-factor Xa levels in patientsreceiving prophylactic enoxaparin perioperatively? Surgery, 161(2), 329-331.

Rondina, Page 20

87. Manne BK, Xiang SC, Rondina MT (2017). Platelet secretion in inflammatory and infectiousdiseases. Platelets, 28(2), 155-164.

88. Kapur R, Kim M, Aslam R, McVey MJ, Tabuchi A, Luo A, Liu J, Li Y, Shanmugabhavananthan S,Speck ER, Zufferey A, Yousef G, Zhang H, Rondina MT, Weyrich AS, Porcelijn L, Kuebler WM,Slutsky AS, Semple JW (2017). T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10. Blood, 129(18), 2557-2569.

89. van Es N, Le Gal G, Otten HM, Robin P, Piccioli A, Lecumberri R, Jara-Palomares L, Religa P,Rieu V, Rondina MT, Beckers MM, Prandoni P, Salaun PY, Nisio MD, Bossuyt PM, Buller HR,Carrier M (2017). Screening for cancer in patients with unprovoked venous thromboembolism:protocol for a systematic review and individual patient data meta-analysis. BMJ Open, 7(6),e015562.

90. Rezania S, Puskarich MA, Petrusca DN, Neto-Neves EM, Rondina MT, Kline JA (2017). Platelethyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism.Thromb Res, 155, 106-115.

91. Kapur R, Kim M, Rebetz J, Rondina MT, Porcelijn L, Semple JW (2017). Low levels ofinterleukin-10 in patients with transfusion-related acute lung injury. Ann Transl Med, 5(16), 339.

92. Cox N, Johnson SA, Vazquez S, Fleming RP, Rondina MT, Kaplan D, Chauv S, Fontaine GV,Stevens SM, Woller S, Witt DM (2017). Patterns and Appropriateness of Thrombophilia Testing inan Academic Medical Center. J Hosp Med, 12(9), 705-709.

93. van Es N, Gal GL, Otten HM, Robin P, Piccioli A, Lecumberri R, Palomares LJ, Religa P, Rieu V,Rondina MT, Beckers MM, Prandoni P, Salaun PY, Nisio MD, Bossuyt PM, Buller HR, Carrier M(2017). Screening for occult cancer in patients with unprovoked venous thromboembolism: asystematic review and individual patient deta meta-analysis. Ann Intern Med, 167(6), 410-417.

94. Campbell RA, Vieira-de-Abreu A, Rowley JW, Franks ZG, Manne BK, Rondina MT, Kraiss LW,Majersik JJ, Zimmerman GA, Weyrich AS (2017). Clots Are Potent Triggers of Inflammatory CellGene Expression: Indications for Timely Fibrinolysis. Arterioscler Thromb Vasc Biol, 37(10), 1819-1827.

95. Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, Preston SD, Southwood M,Hernandez-Sanchez J, Martin J, Treacy C, Yates K, Bogaard H, Church C, Coghlan G, Condliffe R,Corris PA, Gibbs S, Girerd B, Holden S, Humbert M, Kiely DG, Lawrie A, Machado R, MacKenzieRoss R, Moledina S, Montani D, Newnham M, Peacock A, Pepke-Zaba J, Rayner-Matthews P,Shamardina O, Soubrier F, Southgate L, Suntharalingam J, Toshner M, Trembath R, NoordegraafAV, Wilkins MR, Wort SJ, Wharton J, NIHR BioResource–Rare Diseases Consortium, RondinaM (2017). Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort ofPatients Diagnosed Clinically With Pulmonary Arterial Hypertension. Circulation, 136(21), 2022-2033.

96. Stewart LK, Nordenholz KE, Courtney M, Kabrhel C, Jones AE, Rondina MT, Diercks DB,Klinger JR, Kline JA (2017). Comparison of acute and convalescent biomarkers of inflammation inpatients with acute pulmonary embolism treated with systemic fibrinolysis vs. placebo. BloodCoagul Fibrinolysis, 28(8), 675-680.

97. Schwertz H, Rowley JW, Zimmerman GA, Weyrich AS, Rondina MT (2017). Retinoic acidreceptor-alpha regulates synthetic events in human platelets. J Thromb Haemost, 15(12), 2408-2418.

Rondina, Page 21

98. Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK,Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, GuCS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, RazdanR, VanderWoude E, Marques V, Kearon C, Rondina MT (2017). Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis. N Engl J Med, 337(23), 2240-2252.

99. Morales-Ortiz J, Rondina MT, Brown SM, Grissom C, Washington AV (2018). High Levels ofSoluble Triggering Receptor Expressed on Myeloid Cells-Like Transcript (TLT)-1 Are AssociatedWith Acute Respiratory Distress Syndrome. Clin Appl Thromb Hemost, 1076029618774149.

100. Campbell RA, Franks Z, Bhatnagar A, Rowley JW, Manne BK, Supiano MA, Schwertz H, WeyrichAS, Rondina MT (2018). Granzyme A in Human Platelets Regulates the Synthesis ofProinflammatory Cytokines by Monocytes in Aging. J Immunol, 200(1), 295-304.

101. Farmery JHR, Smith ML, NIHR BioResource - Rare Diseases, Rondina M, Lynch AG (2018).Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genomesequencing data. Sci Rep, 8(1), 1300.

102. Bass AR, Szymonifka JD, Rondina MT, Bogardus M, Scott MG, Woller SC, Stevens SM, Eby C,Merritt K, Valle AGD, Moskowitz G, Flores E, Gage BF (2018). Postoperative Myocardial Injuryand Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients. HSS J,14(1), 67-76.

103. Cloutier N, Allaeys I, Marcoux G, Machlus KR, Mailhot B, Zufferey A, Levesque T, Becker Y,Tessandier N, Melki I, Zhi H, Poirier G, Rondina MT, Italiano JE, Flamand L, McKenzie SE, CoteF, Nieswandt B, Khan WI, Flick MJ, Newman PJ, Lacroix S, Fortin PR, Boilard E (2018). Plateletsrelease pathogenic serotonin and return to circulation after immune complex-mediated sequestration.Proc Natl Acad Sci U S A, 115(7), E1550-E1559.

104. Middleton EA, Rondina MT, Schwertz H, Zimmerman GA (2018). Amicus or AdversaryRevisited: Platelets in Acute Lung Injury & Acute Respiratory Distress Syndrome.LID -10.1165/rcmb.2017-0420TR [doi]. (Epub ahead of print) Am J Respir Cell Mol Biol.

105. Manne BK, Munzer P, Badolia R, Allgaier BW, Campbell RA, Middleton E, Weyrich AS, KunapuliSP, Borst O, Rondina MT (2018). PDK1 governs thromboxane generation and thrombosis inplatelets by regulating activation of Raf1 in the MAPK pathway.LID - 10.1111/jth.14005 [doi].(Epub ahead of print) J Thromb Haemost.

106. Schwertz H, Rowley JW, Schumann GG, Thorack U, Campbell RA, Manne BK, Zimmerman GA,Weyrich AS, Rondina MT (2018). Endogenous LINE-1 (Long Interspersed Nuclear Element-1)Reverse Transcriptase Activity in Platelets Controls Translational Events Through RNA-DNAHybrids. Arterioscler Thromb Vasc Biol, 38(4), 801-815.

107. Yuhong L, Tana W, Zhengzhong B, Feng T, Qin G, Yingzhong Y, Wei G, Yaping W, Langelier C,Rondina MT, Ge RL (2018). Transcriptomic profiling reveals gene expression kinetics in patientswith hypoxia and high altitude pulmonary edema. Gene, 651, 200-205.

108. Machin DR, Bloom SI, Campbell RA, Phuong TTT, Gates PE, Lesniewski LA, Rondina MT,Donato AJ (2018). Advanced age results in a diminished endothelial glycocalyx.LID -10.1152/ajpheart.00104.2018 [doi]. (Epub ahead of print) Am J Physiol Heart Circ Physiol.

109. Guo L, Kapur R, Aslam R, Hunt K, Hou Y, Zufferey A, Speck ER, Rondina MT, Lazarus AH, NiH, Semple JW (2018). Antiplatelet antibody-induced thrombocytopenia does not correlate withmegakaryocyte abnormalities in murine immune thrombocytopenia. Scand J Immunol, 88(1),e12678.

NON PEER-REVIEWED JOURNAL ARTICLES

Rondina, Page 22

1. Manne BK, Rondina MT (2018). PDK1 governs thromboxane generation and thrombosis in plateletsby regulating activation of Raf1 in the MAPK pathway: Reply.LID - 10.1111/jth.14230 [doi]. (Epubahead of print) J Thromb Haemost.

BOOK CHAPTERS1. Harris ES, Rondina MT, Schwertz H, Weyrich AS, Zimmerman GA (2010). Pathogenesis of sepsis

and sepsis-induced acute lung injury. In A.M.K. Choi (Ed.), Acute Respiratory Distress Syndrome,Second Edition (pp. 369-419). Informa Healthcare.

2. Rondina MT, Weyrich AS (2012). Targeting Phosphodiesterases in Anti-Platelet Therapy. InGresele, P. (Eds.), Antiplatelet Agents, Handbook of Experimental Pharmacology (210, pp. 225-38). Berlin: Springer-Verlag.

3. Vieira de Abreu A, Rondina MT, Weyrich AS, Zimmerman GA (2013). Inflammation. In A. D.Michelson (Ed.), Platelets, 3rd Edition (pp. 733-766). London: Elsevier.

4. Johnson SA, Rondina MT (2015). Coagulation Disorders. In Hazzard's Geriatric Medicine andGerontology (7th).

5. Rondina MT, Farrukh H (2016). Venous Thromboembolism. In Findeiss LK (Ed.), VenousInterventional Radiology (1st).

6. Rondina MT, Garraud O, Schwertz H (2016). Platelets and Bacterial Infections. In Gresele P, Lopez,JA, Kleiman NS (Eds.), Platelets in Thrombotic and Non-Thrombotic Disorders (2nd).

OTHER (Commentary/Letters/Editorials/Case Reports/Video/Film)

Letters1. Kaplan D, Rondina MT (2016). Response [Letter to the editor]. Chest, 149(4), 1107-8.2. Schwertz H, Rondina MT (2018). Retinoic acid receptor-alpha regulates synthetic events in human

platelets: reply.LID - 10.1111/jth.13995 [doi] [Letter to the editor]. J Thromb Haemost.

Other1. Contreras JL, Dere W, Rondina MT, and Francis LP (2016). Frontiers in Precision Medicine:

Exploring Science and Policy Boundaries. SSRN.

RECENTLY PUBLISHED ABSTRACTS (Last 3 Years)1. Davizon-Castillo P, Ashworth K, Higa K, Hernandez G, Acharya S, Campbell RA, Rondina MT,

Collins CB, Donato A, Lesniewski L, DeGregori J, Holer M, Banda N, Di Paola J, Pietras EM (2016).Pro-Inflammatory Cytokines Drive the Development of a Prothrombotic Platelet Phenotype inInflammation and Aging (poster 3747) [Abstract]. Blood, 2016(128), 3747.

2. Shih LC, Kaplan D, Kraiss LW, Casper TC, Pendleton RC, Peters CL, Supiano MA, Zimmerman GA,Weyrich AS, Rondina MT (2016). Circulating Platelet-Monocyte Aggregates Predict VenousThromboembolism in Older Adults Undergoing Major Orthopedic Surgery [Abstract]. Blood,2015(126), 2308.

3. Patel P, Walborn A, Hoppensteadt D, Mosier M, Rondina MT, Fareed J (2016). Biomarkers ofInflammation and Infection in Sepsis Associated Disseminated Intravascular Coagulation andTheir Prognostic Role [Abstract]. Blood, 2016(128), 3747.

4. Walborn A, Patel P, Hoppensteadt D, Mosier M, Rondina MT, Fareed J (2016). ExtracellularNucleosome Levels in the Etiopathogenesis of Sepsis Associated Coagulopathy [Abstract].Blood, 2016(128), 564.

Rondina, Page 23

5. Campbell RA, Bhatnagar A, Franks Z, Rowley JW, Manne B, Supiano M, Schwertz H, Weyrich A,Rondina M (2017). Aging-Associated Increases in Platelet Granzyme A Regulates Pro-Inflammatory Gene Synthesis by Target Monocytes [Abstract]. Oral Communication, 58.2.

6. Middleton EA, Campbell RA, Grissom CK, Brown SM, Schwertz H, Manne BK, Guo L, Paine R,Harris ES, Rowley JW, Zimmerman GA, Weyrich AS, Rondina MT (2018). Platelet Integrin GeneExpression and Function are Upregulated in Sepsis and Associated with Mortality [Abstract].SHOCK Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, 49(1), 18.

7. Campbell RA, Schwertz H, Hottz ED, Rowley JW, Tolley ND, Zimmerman GA, Bozza FA, WeyrichAS, Rondina MT (2018). Type I Interferons Upregulate IFITM3 in Human Platelets andMegakarocytes to Control Viral Infectivity [Abstract]. SHOCK Injury, Inflammation, and Sepsis:Laboratory and Clinical Approaches, 49(1), 126.

8. Guo L, Shen S, Rowley JW, Su J, Jia W, McComas K, Krauel K, Campbell RA, Manne BK, Jacob S,Middleton EA, Zimmerman GA, Weyrich AS, Rondina MT (2018). Increased Platelet MHC IExpression During Severe Sepsis Impairs CD8+ Cell Responses [Abstract]. SHOCK Injury,Inflammation, and Sepsis: Laboratory and Clinical Approaches, 49(1), 22.

9. Campbell RA, Manne BK, Saperstein S, Page L, Schwertz H, Rowley JW, Weyrich AS, RondinaMT (2018). Interferon-Induced Transmembrane 3 (IFITM3) on Megakaryocytes and PlateletsRegulates Fibrinogen Endocytosis and Thrombosis During Severe Sepsis [Abstract]. SHOCKInjury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, 49(1), 136.

UNPUBLISHED POSTER PRESENTATIONS1. Nance D, Campbell RA, Rowley JW, Downie JM, Jorde LB, Kahr WH, Smock KJ, Mereby SA,

Manne BK, Tolley ND, Zimmerman GA, Weyrich AS, Rondina MT (2016). Combined Variants inFactor VIII and PTGS-1 Amplify Hemorrhage Severity Across Three Generations ofDescendants. Poster session presented at THSNA National Meeting, Chicago, IL.

2. Castillo PD, Ashworth KJ, Higa K, Hernandez G, Campbell RA, Rondina MT, Collins CB, DonatoAJ, Lesniewski LA, DeGregori J, Pietras E, Di Paola J (2016). Aging-associated inflammationpromotes the development of a platelet prothrombotic phenotype. Poster session presented atGRC Hemostasis Meeting, Stowe, VT.

3. Patel P, Walborn A, Hoppensteadt D, Mosier M, Rondina MT, Fareed J (2016). Biomarkers ofInflammation and Infection in Sepsis Associated Disseminated Intravascular Coagulation andTheir Prognostic Role (poster 1412). Poster session presented at ASH Scientific Meeting, SanDiego, CA.

4. Wegryzn G, Hoppensteadt D, Walborn A, D’Almeida Maia P, Walborn S, Green R, Mosier M,Rondina MT, Fareed J (2017). Biomarkers of Platelet Activation and Their Prognostic Value inPatients in Sepsis Associated Coagulopathy (Poster 3632). Poster session presented at ASH,Atlanta, GA.

5. Walborn A, Patel P, Hoppensteadt D, Mosier M, Rondina M, Fareed J (2017). ExtracellularNucleosome Levels in the Etiopathogenesis of Sepsis-Associated Coagulopathy (PosterPB323). Poster session presented at ISTH, Berlin, Germany.

6. Walborn A, Patel P, Hoppensteadt D, Mosier M, Rondina M, Fareed J (2017). Mediators ofInflammation and Infection in Sepsis Associated Disseminated Intravascular Coagulation andTheir Prognostic Role (Poster PB324). Poster session presented at ISTH, Berlin, Germany.

7. Maguire C, Nicholes D, Tristani-Firouzi M, Shcheglovitov A, Rondina MT (2017). Human InducedPluripotent Stem Cells for Modeling Disease (poster A173). Poster session presented atTranslational Science, Washington, DC.

Rondina, Page 24

8. Guo Li, Shen S, Rowley JW, McComas K, Su J, Manne BK, Berger B, Middleton E, Campbell RA,Weyrich AS, Rondina MT (2017). Increased MHC Class I Expression on Platelets in Humanand Murine Sepsis (Poster 1036). Poster session presented at ASH, Atlanta, GA.

9. Shih L, Rondina M, Guler N, Syed D, Walborn A, Hoppensteadt D, Fareed J (2017). Pro-Angiogenic Biomarkers are Upregulated in Patients with Advanced Osteoarthritis UndergoingOrthopedic Surgery (Poster PB2434). Poster session presented at ISTH, Berlin, Germany.

10. Shah R, Steinberg B, Bucher B, Chapman A, Lloyd-Jones D, Rondina MT, Chapman W (2017).Developing a Corpus for Natural Language Processing to Identify Bleeding Complicationsamong Intensive Care Unit Patients (poster B54). Poster session presented at TranslationalScience, Washington, DC.

11. Schwertz HJ, Rowley JW, Kraiss LW, Campbell RA, Zimmerman GA, Schumann GG, Thorack U,Weyrich AS, Rondina MT (2017). Endogenous Reverse Transcriptase (LINE-1) in HumanPlatelets Regulates Cell Morphology and Protein Synthetic Events (poster A145). Poster sessionpresented at Translational Science, Washington, DC.

12. Campbell RA, Bhatnagar A, Franks Z, Rowley JW, Manne BK, Supiano MA, Rondina MT (2017).Aging-Associated Increases in Platelet Granzyme A Regulate Pro-Inflammatory Gene Synthesisby Monocytes (poster B110). Poster session presented at Presidential Poster Session, AmericanGeriatric Society, San Antonio, TX.

13. Walborn A, Wegryzn G, Walborn S, D’Almeida Maia P, Mosier M, Hoppensteadt D, Rondina MT,Fareed J (2017). Biomarkers of Endothelial Function in Sepsis-Associated DisseminatedIntravascular Coagulation. (Poster 1084). Poster session presented at ASH, Atlanta, GA.

14. Basak I, Bhatlekar S, Campbell RA, Chahdi A, Kong X, Ma L, Rondina MT, Weyrich AS, EdelsteinLC, Bray PF (2017). MiR-15a-5p Regulates Multiple Components of GPVI-Mediated Plateletand Megakaryocyte Activation Pathway (Poster 1021). Poster session presented at ASH, Atlanta,GA.

15. Campbell RA, Shi D, Winters J, Bhatlekar S, Manne B, Jiang A, Saperstein S, Rondina MT, BrayPF, Weyrich AS (2017). Calcium/calmodulin-dependent Protein Kinase II (CamKII) RegulatesPlatelet formation (poster PB546). Poster session presented at ISTH, Berlin, Germany.

16. Eustes AS, Manne BK, Schwertz H, Vieira-de-Abreu A, Rowley JW, Middleton EA, Campbell RA,Rondina MT, Weyrich AS (2017). Adhesion Dependent Formation of a Golgi Apparatus inHuman Platelets in Health and Disease (poster 7). Poster session presented at GRC Cell Biologyof Megakaryocytes and Platelets, Barga, Italy.

ORAL PRESENTATIONS

Keynote/Plenary LecturesInternational2018 Rondina MT. Novel Roles for Platelets in Health and Disease. International

Society for Blood Transfusion, Toronto, Canada

Meeting Presentations (Not Published Abstracts and Not Unpublished Posters)International

Rondina, Page 25

2012 Rondina MT, Lam UT, Pendleton RC, Kraiss LW, Wanner N, Zimmerman GA,Hanrahan C, Boucher K, Hoffman JM, Morton KA. The role of 18-flourine-fluorodeoxyglucose positron emission tomography in the evaluation of deepvein thrombosis. International Conference on Thrombosis and Hemostasis Issuesin Cancer, Bergamo, Italy

2012 Rondina MT, Kalva S, Grissom CK, Zimmerman GA, Men S, Tolley ND, HarrisES, Weyrich AS. Platelet Reprogramming During Critical Illness: MolecularCharacterization in Patients with Bacterial Sepsis and H1N1 Influenza.International Platelet Symposium, Boston, MA

2013 Kline J, Kabrhel C, Courtney M, Diercks D, Jones A, Nordenholz K, RondinaMT, Klinger J, Hernandez J. Quality of life outcomes in a randomized trial oftenecteplase versus placebo for submassive pulmonary embolism. InternationalSociety on Thrombosis and Haemostasis, Amsterdam, Netherlands.

2014 Rondina MT, Schwertz H, Tolley ND, Weyrich AS. Megakaryocytes andplatelets sense and respond to infectious cues. 8th International PlateletSymposium. Jerusalem, Israel.

2015 Bhatnagar A, Campbell, RC, Franks Z, Rowley JW, Weyrich AS, Supiano AS,Rondina MT. Granzyme A is Increased in Platelets from Older HealthyAdults, Increasing MCP-1 and IL-8 Synthesis in Target Monocytes.Immunosenescence International Meeting, Vienna, Austria

2015 Bhatnagar A, Campbell, RC, Franks Z, Rowley JW, Weyrich AS, Supiano AS,Rondina MT. Platelet Granzyme A Induces Inflammatory Cytokine Synthesisin Monocytes and Aging. Biology of Aging Symposium, Singapore

2015 Schwertz H, Freitag M, Rowley JW, Kraiss LW, Franks Z, Zimmerman GA,Weyrich AS, Rondina MT. Non-Genomic Activities of REtinoic Acid ReceptorAlpha Control Actin Cytoskeletal Events in Human platelets. InternationalSociety of Thrombosis and Haemostasis Congress

2017 Bhatlekar S, Nagalla S, Lindsey C, Ma L, Kong X, Basak I, Pellegrino da silva R,Yichuan L, Rondina M, Weyrich A, Edelstein L, Bray P, miR-125a-5p RegulatesMegakaryocyte Differentiation and Proplatelet Formation (OralCommunication 38.4). ISTH, Berlin, Germany.

2017 Walborn A, Patel P, Hoppensteadt D, Mosier M, Rondina M, Fareed J,Relationship of Markers of Inflammation, Infection, and Endothelial Functionto Mortality and Severity of Coagulopathy in Patients with Sepsis-AssociatedDIC (Oral Communication 36.4). ISTH, Berlin, Germany

2017 Campbell RA, Manne B, Saperstein S, Schwertz H, Rowley J, Weyrich A,Rondina M. Interferon-induced Transmembrane 3 (IFITM3) onMegakaryocytes and Platelets Regulates Fibrinogen Endocytosis andThrombosis During Inflammation (Oral Communication 70.2). ISTH, Berlin,Germany.

2017 Van Es N, Bertoletti L, Jara-Palomares L, Le Gal G, Otten HM, Piccioli A, ReligaP, Lecumberri R, Rieu V, Rondina M, Beckers M, Robin P, Prandoni P, Di NisioM, Bossuyt PM, Buller HR, Carrier M, Salaun PY. Screening for Cancer inPatients with Unprovoked Venous Thromboembolism: Systematic Review froman Individual Patient Data Meta-Analysis (Oral Communication 21.3). ISTH,Berlin, Germany

Rondina, Page 26

2017 Van Es N, Bertoletti L, Jara-Palomares L, Le Gal G, Otten HM, Piccioli A, ReligaP, Lecumberri R, Rieu V, Rondina M, Beckers M, Robin P, Prandoni P, Di NisioM, Bossuyt PM, Buller HR, Carrier M, Salaun PY. External Validation of a RiskScore for Occult Cancer in Patients with Unprovoked VenousThromboembolism: Results from an Individual Patient Data Meta-Analysis(Oral Communication 21.3). ISTH, Berlin, Germany

National2007 Van Tassell B, Rondina M, Huggins F, Munger M, Gilbert EM. Carvedilol

Exhibits No Tolerance to a1-Receptor Blockade in Class C Heart FailureSubjects. 11th Annual Scientific Meeting of the Heart Failure Society of America,Washington DC

2007 Van Tassell B, Rondina M, Munger M. The Effects of Calcitriol (1a, 25-[OH]2vitamin D3) on Renin Expression in Hypertensive Patients without Vitamin DDeficiency. American College of Clinical Pharmacy Meeting, Denver, CO

2007 Van Tassell B, Rondina M, Huggins F, Munger M, Gilbert EM. CarvedilolIncreases Blood Pressure Response to Phenylephrine Infusion in Class CHeart Failure Subjects: Evidence of Improved Vascular a1-receptor signaltransduction. American College of Clinical Pharmacy Meeting, Denver, CO

2009 Rondina MT. Clinical Cases in Anticoagulation Management. Advances inInternal Medicine Symposium, University of Utah Health Sciences Center, SaltLake City, UT

2009 Rondina MT. Hospital Medicine News Flash. Advances in Internal MedicineSymposium, University of Utah Health Sciences Center, Salt Lake City, UT

2011 Rondina MT, Wanner N, Pendleton RC, Kraiss LW, Vinik R, Zimmerman GA,Heilbrun M, Hoffman JM, Morton KA. A pilot study utilizing whole body FDG-PET/CT as a comprehensive screening strategy for occult malignancy inpatients with unprovoked VTE. Society of Vascular Medicine Meeting, Boston,MA

2012 Rondina MT. Age-Dependent Platelet-Monocyte Aggregate Formation in theSeptic Milieu Predicts Mortality. American Geriatric Society National Meeting,Seattle, WA

2013 Rondina MT, Campbell RA, Franks Z, Holloway TH, Fraughton T, ZimmermanGA, Supiano MA, Weyrich AS, Platelet-Monocyte Interactions and Pro-Inflammatory Gene Synthesis is Increased in Healthy, Elderly Subjects. J AmGeriatr Soc. Galveston, TX.

2013 Rondina MT. TOPCOAT Investigators. Randomized Trail of Tenecteplase ofPlacebo with Low Molecular Weight Heparin for Acute SubmassivePulmonary Embolism: Assessment of Patient-Oriented CardiopulmonaryOutcomes at Three Months. American College of Cardiology Conference.

2013 Rondina MT. Interferon-Induced Transmembrane (IFITM) Proteins areUpregulated in Human Platelets: Novel Immune Sensing of H1N1 Influenzaand Other Pathogens. Gordon Research Conference, Galveston TX.

2013 Rondina MT. VTE Prevention: Avoiding the Avoidable in Medical and HighRisk Patients. American College of Physicians/Pri-Med Annual Conference Mid-West.

Rondina, Page 27

2013 Rondina MT. My Approach to the New Oral Anticoagulants. American HeartAssociation Peripheral Vascular Disease Workshop

2015 Campbell RA, Rowley JW, Weyrich AS, Rondina MT. Surface IFITMs onMegakaryocytes and Platelets Regulate Fibrinogen Endocytosis UnderInflammatory Conditions. American Society of Hematology, Orlando, FL.

2015 Shih L, Sanders N, Weyrich AS, Carlisle M, Men S, Mereby S, Supiano MA,Zimmerman GA, Rondina MT. Activated Platelet Integrin αIIbβ3 is Increasedin Older Adults with Frailty But Not in Healthy Aging. American GeriatricSociety National Meeting, MSTAR Awardee

2016 Morales JF, Reyes OS, Staback F, Pacheco A, Schneider D, Rondina MT,Washington AV. Emerging role for TLT-1 at the interception of inflammationand hemostasis. GRC Hemostasis Meeting, Stowe, VT.

2016 Koliopoulou A, Rondina MT, Javan H, Men S, Drakos SG, Stehlik J, McKellarSH, Weyrich AS, Selzman CH. Platelet Reprogramming with Chronic LVADSupport. ISHLT, Washington, DC

2016 Campbell RA, Bhatnagar A, Franks Z, Rowley JW, Manne BK, Supiano MA,Weyrich AS, Rondina MT. Granzyme G in human platelets regulates pro-inflammatory gene synthesis in aging. U13 GEMSSTAR Meeting, Bethesda,MD

2016 Bhatnagar A, Campbell, RC, Manne B, Weyrich AS, Rondina MT. Granzyme Ais Increased in Platelets From Older Adults, Leading to IL-8 and MCP-1Cytokine Synthesis by Target Monocytes. Western Regional Meeting, CarmelCA.

2017 Rowley JW, Campbell RA, Schwertz H, Weyrich AS, Tolley ND, Voora D,Rondina MT. Transcript Expression, Intron Retention, and RNA Editing AreConserved in Human Platelets over a 4 Year Period (Oral Communication456). ASH, Atlanta, GA

2017 Davizon-Castillo P, Jones KL, Aguila S, Bark D, Ashworth KJ, Higa K, PietrasEM, Campbell RA, Shih LC, Saunders N, DeGregori J, Rondina MT, Di Paola J.Aging-Associated Inflammation Due to Elevated Levels of TNF-α IncreasesActivation of the Integrin αIIbβ3 and the Procoagulant Potential of Platelets.ASH, Atlanta, GA

2017 Manne BK, Munzer P, Badolia R, Weyrich AS, Kunapuli SP, Borst O, RondinaMT, Crosstalk between Phosphotidylinositol-4,5 Bisphosphonate-3 kinasePathway and Mitogen-activated protein kinase Pathway Regulates PlateletActivation and Protein Synthesis via Phorphoionositide-dependent kinase-1.ATVB, Minneapolis, MN

Local/Regional2008 Rondina MT. Secondary VTE Treatment: How Long to Treat with Warfarin

and the Role of Long-Term Low-Molecular Weight Heparin. University of UtahHealth Sciences Center, Annual Thrombosis Symposium, University of Utah, SaltLake City, UT

2009 Rondina MT. Sepsis Induces Expression of Mature Tissue Factor mRNA inHuman Platelets. Annual Molecular Medicine Research Meeting Univerisity ofUtah Health Sciences Center, Park City, UT

Rondina, Page 28

2010 Rondina MT. Emerging Anticoagulants: Review of Pharmacology andClinical Trials. Hospitalist Medicine Update, University of Utah Health SciencesCenter, Salt Lake City, UT

2010 Rondina MT. Heparin-induced Thrombocytopenia: Update and futuredirections. Western Regional Thrombosis Symposium, University of Utah HealthSciences Center, Salt Lake City, UT

2010 Rondina MT. Dosing Parenteral Anticoagulatns in Special Populations: AFocus on the Obese Patient and Patients with Prior HIT. University of UtahHealth Care Thrombosis Regional Conference, Salt Lake City, UT

2011 Rondina MT, Weyrich AS. Reprogrammed Platelets: Effectors of Thrombosisin Metabolic Syndromes. University of Utah Health Sciences Center, Salt LakeCity, UT

2011 Rondina MT. Contemporary Issues in the Management of Acute VTE.Advances in Internal Medicine Annual Meeting, University of Utah, Park City, UT

2012 Rondina MT. Venous Thromboembolism Prevention in Patients with MorbidObesity. Western Regional Thrombosis Symposium. University of Utah HealthSciences Center

2012 Rondina MT. Reprogrammed Platelets As Versatile Effector Cells inInfectious and Inflammatory Syndromes. University of Utah HematologyConference

2013 Rondina MT. The New Anticoagulants. University of Utah 6th BiennialAdvances in Internal Medicine Conference.

2016 Rupp A, Shah R, Mowery D, Stoddard G, Deshmukh V, Bray B, Hess R, RondinaMT. Stroke Prevention Rates in Atrial Fibrillation before and after theIntroduction of Direct Oral Anticoagulants. 11th Annual Health ServicesResearch Conference: Partnering For Better Health: Bringing Utah’s PatientVoices to Research, University of Utah Health Services Research Meeting.

2018 Rondina, MT. Platelets as Immune Cells: Novel Effector Functions for HostDefense, University of Utah, III Initiative Spring Symposium 2018

2018 Rondina MT. Inflammation regulates platelet gene expression andthrombosis. University of Utah, Hematology Symposium, Deer Valley, UT

Invited/Visiting Professor PresentationsInternational2013 Rondina MT. Platelets and Megakaryocytes are Dynamic Immune Effector

Cells in Viral Infectious Syndromes. Greisfwald University, Germany.2014 Rondina MT. Novel Platelet Functions in Health and Disease. Greifswald

University, Greifswald, Germany2014 Rondina MT. Emerging Functions of Platelets During Hypoxia and High-

Altitude Conditions. Qinghai Medical University & High-Altitude ResearchCenter, Xining, China

2015 Rondina MT. The Prevention and Treatment of Venous Thromboembolism inSurgical Patients. Hohhot Orthopedic Specialty Hospital, Inner Mongolia

2015 Rondina MT. Novel Platelet Functions in Health and Disease. QinghaiUniversity, Xining City, China

Rondina, Page 29

2015 Rondina MT. Platelets are Dynamic Effector Cells During InfectiousSyndromes. Immunosenescence Meeting, Vienna, Austria

2015 Rondina MT. Platelet-Derived Granzyme A Mediates Pro-InflammatoryMonokine Synthesis in Aging. Biology of Aging Scientific Conference, Singapore

2015 Rondina MT. Platelets: Dynamic and Versatile Effector Cells DuringInfectious Syndromes. University of Puerto Rico Cellular and Molecular Biology,Puerto Rico

2016 Rondina MT. Platelets: Sentinels and Effectors During Pathogen Invasion.University of British Columbia, Centre for Blood Research, British Columbia,Canada

2016 Rondina MT. Altered Gene Expression in Hypobaric Hypoxia Induced LungInjury in Humans During Acute Illness and Following Treatment. High-Altitude Research Collaborative Group, Yushu, China

2016 Rondina MT. Emerging Platelet Functions Bridge Hemostatic and ImmunePathways. Qinghai High Altitude Research Center, Xining City, China

2016 Rondina MT. Novel Platelet Functions in Sepsis. University of Tubingen.Transfusion Medicine Department, Germany

2016 Rondina MT. Novel Platelet Functions in Health and Disease. ISTH-SSC,Platelet Physiology, Montpellier, France

National2009 Rondina MT. Contemporary Issues in the Management of Venous

Thromboembolism. Kapi'Olani Medical Center at Pali Momi, Aiea, HI2009 Rondina MT. The Management of Venous Thromboembolism in Special

Populations and Heparin Induced Thrombocytopenia. Hilo Medical Center,Hilo, HI

2010 Rondina MT. Emerging Anticoagulants: Will Warfarin go the Way of theDinosaur? ISHP Annual Fall Meeting, Cardiovascular and Metabolic Disorders,Sun Valley, ID

2011 Rondina MT. Protein synthesis by activated human platelets: Novel pathwaysfor inflammatory and hemostatic responses. Vascular Medicine Grand Rounds,Cleveland Clinic, Cleveland, OH

2013 Rondina MT. Novel Anticoagulants for the Treatment of VTE. American HeartAssociation, Chicago, IL

2013 Rondina MT. Prevention of VTE in Medically-Ill and Surgical Patients.American College of Physicians/Pri-Med Mid-West, Rosemont, IL

2014 Rondina MT. Direct Oral Anticoagulants in VTE. American Heart Association,Chicago, IL

2014 Rondina MT. VTE Prevention: Avoiding the Avoidable in Medical and HighRisk Patients. American College of Physicians/Pri-Med Annual Conference West& Mid-West.

2014 Rondina MT. Atrial Arrythmias From Fib To Flutter. Vascular EmergenciesConference, Park City, UT

2014 Rondina MT. New Updates In The Diagnosis Of VTE. Vascular EmergenciesConference, Park City, UT

2014 Rondina MT. The New Options For Dual Antiplatelet Therapy. VascularEmergencies Conference, Park City, UT

Rondina, Page 30

2014 Rondina MT. DVT And PE: Systems Needed For Outpatient Treatment.Vascular Emergencies Conference, Park City, UT

2014 Rondina MT. Sepsis From Lactate And Beyond. Vascular EmergenciesConference, Park City, UT

2015 Rondina MT. Choosing a NOAC for my VTE Patient. American HeartAssociation, Orlando, FL

2015 Rondina MT. Platelets: Hemostatic and Immune Effector Cells in Sepsis.Oregon Health Sciences University BME, Oregon

2015 Rondina MT. Platelets Link Inflammation and Thrombosis. 9th Annual PlateletColloquium, Lexington, KY

2015 Rondina MT. Platelets: Dynamic and Versatile Effector Cells DuringInfectious Syndromes. Univ. of Oklahoma Center for Respiratory and InfectiousDisease, Oklahoma

2016 Rondina MT. Platelets and Platelet-Leukocyte Signaling in Health andDisease. Research Initiative for Scientific Enhancement (RISE) Program at theUniversidad Central del Caribe, San Juan, Puerto Rico

2016 Rondina MT. Platelet Shape Change and Signaling During Health andDisease. Loyola University Medical Center (Pathology Grand Rounds), Illinois

2016 Rondina MT. Platelet-Monocyte Interactions and Inflammation in Aging.Biology of Aging Seminar, Yale University, Connecticut

2016 Rondina MT. Novel Platelet Functions in Health and Disease. University ofKentucky Physiology Seminar Series, Kentucky

2016 Rondina MT. Platelet Reprogramming in Sepsis. Gordon Research Conferenceon Hemostasis, Vermont

2016 Rondina MT. Platelets in Infectious Disease. American Society of Hematology,San Diego, CA

2016 Rondina MT. Extended Duration Secondary VTE Prevention: Warfarin,DOACs, and Aspirin. American Heart Association, New Orleans, LA

2017 Rondina MT. Inflammatory Stressors Upregulate Platelet MHC Class I,Modulating T Cell Responses. American Society of Hematology, ImmuneThrombocytopenia Symposium

2017 Rondina MT. Platelet Reprogramming and Thrombosis in Aging. AmericanSociety of Hematology, Hematology and Aging Symposium

2017 Rondina MT. Platelet and Megakaryocyte Gene Expression and FunctionDuring Inflammatory Stress. Cardeza Foundation, Thomas Jefferson University,Philadelphia, PA

2017 Rondina MT. Inflammatory Stressors Alter Megakaryocyte and Platelet GeneExpression and Function. Aab Cardiovascular Research Institute (CVRI),University of Rochester Medical Center

2017 Rondina MT. Inflammatory Stressors Alter Megakaryocyte and Platelet GeneExpression and Function. New York University Lagone Medical Center, NewYork

2017 Rondina MT. Platelet-Derived Granzyme A Mediates Pro-InflammatoryMonokine Synthesis in Aging. Immunity International Conference, Washington,DC

Rondina, Page 31

2017 Rondina MT. Novel Platelet Functions in Health and Disease. University ofPuerto Rico, San Juan, Puerto Rico

2018 Rondina MT. Platelet Reprogramming and Thrombosis During InflammatoryStress. University of Kentucky, Gill Heart and Vascular Institute, Kentucky

Local/Regional2008 Rondina MT. Update in VTE Prevention and Management. Annual

Thrombosis Symposium, University of Utah Health Science Center2009 Rondina MT. Signal-Dependent Regulation of Tissue Factor Gene

Expression in Platelets during Inflammation. Molecular Medicine ResearchRetreat, University of Utah Health Science Center, Park City, UT

2009 Rondina MT. Update in VTE Prevention and Management. Advances inInternal Medicine, University of Utah Health Science Center

2010 Rondina MT. VTE Prevention in Medically-Ill Patients. Western RegionalThrombosis Symposium, University of Utah Health Science Center

2010 Rondina MT. Hot Topics in Hospitalist Medicine. Hospitalist Medicine Update,University of Utah Health Science Center

2011 Rondina MT. Update in VTE Prevention and Management. Advances inInternal Medicine. University of Utah Health Science Center

2012 Rondina MT. VTE Prevention in Medically-Ill Patients. Western RegionalThrombosis Symposium, University of Utah Health Science Center

2013 Rondina MT. Update in VTE Prevention and Management. Advances inInternal Medicine, University of Utah Health Science Center

2015 Rondina MT. Regulation of Gene Expression in Platelets. Human GeneticsInterest Group, University of Utah Health Science Center

2015 Rondina MT. Novel Functions of Platelets in Health and Disease. Division ofHematology/Oncology Fellows Conference, Salt Lake City, UT

2016 Rondina MT. Thrombolysis – Which Patient, Which Technique? ThrombosisGuidelines Update, Intermountain Medical Center, Salt Lake City, UT

2016 Rondina MT. Personalized Approach to Anticoagulation. Foundations inPersonalized Health Care, University of Utah Health Science Center

2018 Rondina MT. Curiosity and Creativity in Science. University of Utah, MedicalStudent Research Program, Salt Lake City, UT

Grand Rounds Presentations1997 Rondina MT. The Effect of Drilling Parameters upon In Vitro and In Vivo

Heat Generation. Department of Orthopedic Surgery, University of Utah HealthSciences Center, Salt Lake City, UT

2005 Rondina MT. The Emergence of Stress Cardiomyopathy: A Novel HeartSyndrome. Department of Internal Medicine, University of Utah Health SciencesCenter, Salt Lake City, UT

2007 Rondina MT. The Prevention and Treatment of Venous Thromboembolism. St.Peter's Medical Center, Helena, MT

2007 Rondina MT. Beyond the Nucleus: Novel Platelet Activities in Sepsis,Department of Internal Medicine. University of Utah Health Sciences Center, SaltLake City, UT

Rondina, Page 32

2008 Rondina MT. The Prevention of Venous Thromboembolism in Medically-IllPatients. St. Mary’s Hospital and Medical Center, Tucson, AZ

2008 Rondina MT. Venous Thromboembolism Prevention and Treatment in 2008,Department of Pharmacy. University of Utah Health Sciences Center, Salt LakeCity, UT

2009 Rondina MT. Contemporary Issues in VTE Prevention and Treatment.Department of Preventative and Family Medicine, University of Utah HealthSciences Center, Salt Lake City, UT

2009 Rondina MT. VTE Prevention and Treatment: Focus on Factor Xa Inhibition.Internal Medicine Grand Rounds, Fort Harrison Veterans Hospital, Helena, MT

2009 Rondina MT. Critical Illness is Associates with Changes in the PlateletTranscriptome. Department of Pulmonary and Critical Care Medicine,Intermountain Medical Center, Salt Lake City, UT

2010 Rondina MT. The Outpatient Treatment of Acute Venous Thromboembolism.Mountain View Medical Center, Payson, UT

2011 Rondina MT. Update in VTE Prevention and Management. Internal MedicineGrand Rounds (Co-Presenter), Salt Lake City, UT

2011 Rondina MT. Novel Platelet Functions in Health and Inflammation. InternalMedicine Grand Rounds, Salt Lake City, UT

2011 Rondina MT. Anticoagulant Therapy Update. University of Utah HealthSciences Center, Salt Lake City, UT

2012 Rondina MT. Novel Platelet Functions in Health and Inflammation. Divisionof Hematology, Salt Lake City, UT

2013 Rondina MT. Anti-Thrombotic Therapy in Geriatrics: PracticalConsiderations in a Higher-Risk Population. Division of Geriatrics, Universityof Utah Health Sciences Center, Salt Lake City, UT

2013 Rondina MT. Platelets: Dynamic Immune Effector Cells During InfectiousSyndromes. Internal Medicine Grand Rounds, University of Utah Health SciencesCenter, Salt Lake City, UT

2015 Rondina MT. Novel Platelet Functions in Health and Inflammation. Divisionof Hematology, Salt Lake City, UT

2015 Rondina MT. Platelet-Derived Granzyme A Mediates Pro-InflammatoryMonokine Synthesis in Aging. GRECC Research Update, Salt Lake City, UT

2016 Rondina MT. Novel Platelet Functions in Sepsis. Division of Pulmonary/CriticalCare, Salt Lake City, UT

2017 Rondina MT. IFITM3 in Platelets and Megakaryocytes MediatesInflammation-Induced Thrombosis. Department of Pathology Research-in-Progress, Salt Lake City, UT

2017 Rondina MT. Novel Platelet Functions during Aging and Inflammation.GRECC Research Update, Salt Lake City, UT

2018 Rondina MT. Platelets, Immunity, and Thrombosis: Lessons from theHorseshoe Crab. University of Utah, Internal Medicine Grand Rounds, Salt LakeCity, UT

OTHER SCHOLARLY ACTIVITIES

Other Scholarly ActivitiesRondina, Page 33

2011 Invited Facilitator, American Thoracic Society2012 Moderator, Undergraduate Research Symposium (Session: Medicine), University

of Utah2012 - 2013 Proposal Reviewer, American Geriatrics Society Annual Meeting2014 Invited Reviewer, Hematology2014 Invited Early Career Alumni Focus Group Panelist, University of Utah2014 Invited Abstract Reviewer, American College of Cardiology Annual Meeting2015 Invited Abstract Reviewer, American Heart Association Annual Meeting2015 VPR Seed Grant Reviewer (ad Hoc), University of Utah2015 Invited Foreign Scientist, Qinghai Medical University Thesis Defense, China2015 PPH/CCTS Seed Grant Reviewer (ad hoc), University of Utah2016 Invited Oral Abstract Session Chair, American Society of Hematology2016 Education Program Session Chair, American Society of Hematology2016 Faculty Discussion Leader, Gordon Research Seminar on Hemostasis2016 Faculty Discussion Leader, Summer Management Essentials for Principal

Investigators, University of Utah2016 Invited Abstract Reviewer, American Society of Hematology2016 Invited Abstract Reviewer, American Heart Association Annual Meeting2016 University of Toronto External Thesis Appraiser2017 Invited Abstract Reviewer, AHA Congress2017 Invited External Thesis Member, Emilie Montenont, NYU Langone Medical

University2017 Member, University of Utah Precision Medicine Planning Committee2017 Invited Abstract Reviewer, American Geriatric Society2017 Invited Abstract Reviewer, Cell Biology of Megakaryocyte and Platelets2017 Invited Abstract Reviewer, ISTH Congress2017 Chair, ISTH Abstract Symposia Sessions2017 Invited Session Proposal Reviewer, AGS Congress2017 - 2018 Co-Chair, Data Safety and Monitoring Board. Fixed dose heparin in microsurgery

study2017 - 2018 Co-Chair, Data Safety and Monitoring Board. Twice daily enoxaparin in plastic

surgery study2017 - Present Co-Chair, Data Safety and Monitoring Board. Enoxaparin metabolism in surgical

patients study2017 - Present Co-Chair, Data Safety and Monitoring Board. Weight-Based Enoxaparin Dosing

and Real-time Dose Adjustment in Orthopaedic Trauma2017 - Present Co-Chair, Data Safety and Monitoring Board. Fixed vs weight based enoxaparin in

thoracic surgery patients2017 - Present Co-Chair, Data Safety and Monitoring Board. Minimization of bleeding related

adverse drug events in plastic and reconstructice surgery patients randomized todifferent postoperative anticoagulant regimens

2018 Invited Moderator, ISTH SSC Platelet Physiology Session, Dublin, Ireland

Rondina, Page 34